BRAINBYSITE.TXT

AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|All other|2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|17|201002181|Female|All other|2012-2016|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|32|201002181|Female|All other|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40632786|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40460864|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40307649|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Anaplastic astrocytoma|2012-2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|177|201002181|Female|Anaplastic astrocytoma|2012-2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|50|40212686|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40155513|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40153090|Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40173243|Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Anaplastic oligodendroglioma|2012-2016|~|~|~
0-19|~|~|~|Malignant|~|201002181|Female|Anaplastic oligodendroglioma|2012-2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|40632786|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40460864|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|40307649|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Astrocytoma, NOS|2012-2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|434|201002181|Female|Astrocytoma, NOS|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|100|40212686|Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40155513|Female|Astrocytoma, NOS|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|72|40153090|Female|Astrocytoma, NOS|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40173243|Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40632786|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632786|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|40460864|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40460864|Female|Choroid plexus|2011|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|40307649|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40307649|Female|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|127|201002181|Female|Choroid plexus|2012-2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|52|201002181|Female|Choroid plexus|2012-2016|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|40212686|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40212686|Female|Choroid plexus|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40155513|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40155513|Female|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40153090|Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40153090|Female|Choroid plexus|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|40173243|Female|Choroid plexus|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40173243|Female|Choroid plexus|2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|83|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|76|40165421|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40632786|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632786|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|40460864|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40460864|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40307649|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40307649|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|403|201002181|Female|Craniopharyngioma|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|201002181|Female|Craniopharyngioma|2012-2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40212686|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40212686|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40155513|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40155513|Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|40153090|Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40153090|Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40173243|Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40173243|Female|Craniopharyngioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40632786|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Diffuse astrocytoma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|201002181|Female|Diffuse astrocytoma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|216|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|185|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|221|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|205|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|174|40632786|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|40460864|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.4|Malignant|180|40307649|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Embryonal/primitive/medulloblastoma|2012-2016|~|~|~
0-19|0.4|0.5|0.5|Malignant|943|201002181|Female|Embryonal/primitive/medulloblastoma|2012-2016|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|187|40212686|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.5|Malignant|211|40155513|Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|189|40153090|Female|Embryonal/primitive/medulloblastoma|2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.4|0.5|0.4|Malignant|176|40173243|Female|Embryonal/primitive/medulloblastoma|2016|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40460864|Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40460864|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40307649|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40307649|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|68|201002181|Female|Ependymoma variants|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|201002181|Female|Ependymoma variants|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40212686|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40212686|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|40632786|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40460864|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40307649|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Ependymoma/anaplastic ependymoma|2012-2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|431|201002181|Female|Ependymoma/anaplastic ependymoma|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|89|40212686|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|40155513|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40153090|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|77|40173243|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|30|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40632786|Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|53|40632786|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|22|40460864|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|38|40460864|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Germ Cell Tumors|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40307649|Female|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|98|201002181|Female|Germ Cell Tumors|2012-2016|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|204|201002181|Female|Germ Cell Tumors|2012-2016|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40212686|Female|Germ Cell Tumors|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|47|40212686|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40155513|Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|34|40155513|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40153090|Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|45|40153090|Female|Germ Cell Tumors|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40173243|Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|57|40173243|Female|Germ Cell Tumors|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|52|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|59|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40632786|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40460864|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|40307649|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Glioblastoma|2012-2016|~|~|~
0-19|0.1|0.2|0.2|Malignant|335|201002181|Female|Glioblastoma|2012-2016|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40212686|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|40155513|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Glioblastoma|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|40153090|Female|Glioblastoma|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.1|Malignant|55|40173243|Female|Glioblastoma|2016|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|233|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|239|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|246|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|267|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|281|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|296|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.7|Malignant|264|40632786|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|18|40460864|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|307|40460864|Female|Glioma malignant, NOS|2011|0.7|0.8|0.8
0-19|0.0|0.1|0.0|Benign/Borderline|18|40307649|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|229|40307649|Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|82|201002181|Female|Glioma malignant, NOS|2012-2016|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|1349|201002181|Female|Glioma malignant, NOS|2012-2016|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.7|0.8|0.7|Malignant|294|40212686|Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Glioma malignant, NOS|2014|~|~|~
0-19|0.6|0.7|0.7|Malignant|263|40155513|Female|Glioma malignant, NOS|2014|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Glioma malignant, NOS|2015|~|~|~
0-19|0.6|0.7|0.7|Malignant|262|40153090|Female|Glioma malignant, NOS|2015|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|21|40173243|Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.8|Malignant|301|40173243|Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|100|201002181|Female|Hemangioblastoma|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|201002181|Female|Hemangioblastoma|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40212686|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40212686|Female|Hemangioblastoma|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|30|40155513|Female|Hemangioblastoma|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40155513|Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40153090|Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40153090|Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40173243|Female|Hemangioblastoma|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40173243|Female|Hemangioblastoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40382360|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|40632786|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40632786|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|71|40460864|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40460864|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40307649|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40307649|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|301|201002181|Female|Hemangioma|2012-2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|201002181|Female|Hemangioma|2012-2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|40212686|Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40212686|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40155513|Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40155513|Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|68|40153090|Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40153090|Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|40173243|Female|Hemangioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40173243|Female|Hemangioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Local Extensions from Regional Tumors|2012-2016|~|~|~
0-19|~|~|~|Malignant|~|201002181|Female|Local Extensions from Regional Tumors|2012-2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|201002181|Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|40632786|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40632786|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40460864|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40460864|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40307649|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40307649|Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|336|201002181|Female|Meningioma|2012-2016|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|21|201002181|Female|Meningioma|2012-2016|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|76|40212686|Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40212686|Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40155513|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40155513|Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40153090|Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40153090|Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40173243|Female|Meningioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40173243|Female|Meningioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Mixed glioma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|40|201002181|Female|Mixed glioma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Mixed glioma|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|56|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|79|40576293|Female|Neoplasm, unspecified|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|87|40632786|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632786|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40460864|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|20|40460864|Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|40307649|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|40307649|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|348|201002181|Female|Neoplasm, unspecified|2012-2016|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|110|201002181|Female|Neoplasm, unspecified|2012-2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|71|40212686|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40212686|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|77|40155513|Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40155513|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|80|40153090|Female|Neoplasm, unspecified|2015|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|40153090|Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|50|40173243|Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|25|40173243|Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|114|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|162|39998876|Female|Nerve sheath, benign and malignant|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|155|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|128|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40632786|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632786|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40460864|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40460864|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|138|40307649|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40307649|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|651|201002181|Female|Nerve sheath, benign and malignant|2012-2016|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|201002181|Female|Nerve sheath, benign and malignant|2012-2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40212686|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40212686|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|100|40155513|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40155513|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40153090|Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40153090|Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|40173243|Female|Nerve sheath, benign and malignant|2016|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40173243|Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Neuroepithelial|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|32|201002181|Female|Neuroepithelial|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40155513|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|40153090|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Neuroepithelial|2016|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|121|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40632786|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|19|40632786|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|152|40460864|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40460864|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|40307649|Female|Neuronal/glial, neuronal|2012|0.3|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40307649|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|824|201002181|Female|Neuronal/glial, neuronal|2012-2016|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|108|201002181|Female|Neuronal/glial, neuronal|2012-2016|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|160|40212686|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|40212686|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|157|40155513|Female|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|25|40155513|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|168|40153090|Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40153090|Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|184|40173243|Female|Neuronal/glial, neuronal|2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|28|40173243|Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40632786|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40460864|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40307649|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Oligodendroglioma|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|96|201002181|Female|Oligodendroglioma|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40155513|Female|Oligodendroglioma|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40153090|Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40173243|Female|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40632786|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632786|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40460864|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40460864|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40307649|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40307649|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|231|201002181|Female|Other mesenchymal|2012-2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|201002181|Female|Other mesenchymal|2012-2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|40212686|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40212686|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40155513|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40155513|Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40153090|Female|Other mesenchymal|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40153090|Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40173243|Female|Other mesenchymal|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40173243|Female|Other mesenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|329|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|322|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|317|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|334|40382360|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|335|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|350|40670476|Female|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|392|40632786|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|356|40460864|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.8|1.0|0.9|Malignant|374|40307649|Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|201002181|Female|Pilocytic astrocytoma|2012-2016|~|~|~
0-19|0.9|0.9|0.9|Malignant|1795|201002181|Female|Pilocytic astrocytoma|2012-2016|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|362|40212686|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.1|1.0|Malignant|397|40155513|Female|Pilocytic astrocytoma|2014|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|347|40153090|Female|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.7|0.9|0.8|Malignant|315|40173243|Female|Pilocytic astrocytoma|2016|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40632786|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40632786|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40460864|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40460864|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|40307649|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40307649|Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|201002181|Female|Pineal parenchymal|2012-2016|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|81|201002181|Female|Pineal parenchymal|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40212686|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40212686|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40155513|Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40155513|Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40153090|Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40153090|Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40173243|Female|Pineal parenchymal|2016|~|~|~
0-19|~|~|~|Malignant|~|40173243|Female|Pineal parenchymal|2016|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|269|39865121|Female|Pituitary|2004|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|304|39998876|Female|Pituitary|2005|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|350|40165421|Female|Pituitary|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|333|40382360|Female|Pituitary|2007|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|396|40576293|Female|Pituitary|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|390|40670476|Female|Pituitary|2009|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|450|40632786|Female|Pituitary|2010|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40632786|Female|Pituitary|2010|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|454|40460864|Female|Pituitary|2011|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40460864|Female|Pituitary|2011|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|478|40307649|Female|Pituitary|2012|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40307649|Female|Pituitary|2012|~|~|~
0-19|1.1|1.2|1.2|Benign/Borderline|2376|201002181|Female|Pituitary|2012-2016|1.1|1.2|1.2
0-19|~|~|~|Malignant|~|201002181|Female|Pituitary|2012-2016|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|454|40212686|Female|Pituitary|2013|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40212686|Female|Pituitary|2013|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|486|40155513|Female|Pituitary|2014|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40155513|Female|Pituitary|2014|~|~|~
0-19|1.0|1.3|1.1|Benign/Borderline|465|40153090|Female|Pituitary|2015|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40153090|Female|Pituitary|2015|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|493|40173243|Female|Pituitary|2016|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40173243|Female|Pituitary|2016|~|~|~
0-19|1.8|2.1|2.0|Benign/Borderline|786|39865121|Female|Total|2004|1.8|2.1|2.0
0-19|3.1|3.5|3.3|Malignant|1306|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.2|2.5|2.3|Benign/Borderline|945|39998876|Female|Total|2005|2.2|2.5|2.4
0-19|2.9|3.3|3.1|Malignant|1238|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.2|2.5|2.4|Benign/Borderline|960|40165421|Female|Total|2006|2.2|2.5|2.4
0-19|2.9|3.2|3.1|Malignant|1229|40165421|Female|Total|2006|2.9|3.2|3.1
0-19|2.2|2.5|2.4|Benign/Borderline|977|40382360|Female|Total|2007|2.3|2.6|2.4
0-19|3.0|3.4|3.2|Malignant|1296|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.4|2.7|2.6|Benign/Borderline|1060|40576293|Female|Total|2008|2.5|2.8|2.6
0-19|3.0|3.4|3.2|Malignant|1287|40576293|Female|Total|2008|3.0|3.3|3.2
0-19|2.5|2.8|2.6|Benign/Borderline|1082|40670476|Female|Total|2009|2.5|2.8|2.7
0-19|3.0|3.4|3.2|Malignant|1292|40670476|Female|Total|2009|3.0|3.4|3.2
0-19|2.6|3.0|2.8|Benign/Borderline|1149|40632786|Female|Total|2010|2.7|3.0|2.8
0-19|3.0|3.4|3.2|Malignant|1302|40632786|Female|Total|2010|3.0|3.4|3.2
0-19|2.7|3.1|2.9|Benign/Borderline|1180|40460864|Female|Total|2011|2.8|3.1|2.9
0-19|3.2|3.5|3.3|Malignant|1347|40460864|Female|Total|2011|3.2|3.5|3.3
0-19|2.9|3.2|3.0|Benign/Borderline|1228|40307649|Female|Total|2012|2.9|3.2|3.0
0-19|2.9|3.2|3.1|Malignant|1231|40307649|Female|Total|2012|2.9|3.2|3.1
0-19|3.0|3.1|3.0|Benign/Borderline|6122|201002181|Female|Total|2012-2016|3.0|3.1|3.0
0-19|3.1|3.3|3.2|Malignant|6425|201002181|Female|Total|2012-2016|3.1|3.3|3.2
0-19|2.9|3.2|3.0|Benign/Borderline|1227|40212686|Female|Total|2013|2.9|3.2|3.1
0-19|3.2|3.5|3.3|Malignant|1343|40212686|Female|Total|2013|3.2|3.5|3.3
0-19|2.9|3.2|3.0|Benign/Borderline|1220|40155513|Female|Total|2014|2.9|3.2|3.0
0-19|3.2|3.6|3.4|Malignant|1359|40155513|Female|Total|2014|3.2|3.6|3.4
0-19|2.9|3.3|3.1|Benign/Borderline|1246|40153090|Female|Total|2015|2.9|3.3|3.1
0-19|2.9|3.3|3.1|Malignant|1251|40153090|Female|Total|2015|2.9|3.3|3.1
0-19|2.8|3.1|3.0|Benign/Borderline|1201|40173243|Female|Total|2016|2.8|3.2|3.0
0-19|2.9|3.3|3.1|Malignant|1241|40173243|Female|Total|2016|2.9|3.3|3.1
0-19|0.2|0.3|0.3|Benign/Borderline|114|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|162|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|155|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|128|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|143|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|130|40632786|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632786|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40460864|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40460864|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|138|40307649|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40307649|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|651|201002181|Female|Tumors of Cranial and Spinal Nerves|2012-2016|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|201002181|Female|Tumors of Cranial and Spinal Nerves|2012-2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|40212686|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40212686|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|100|40155513|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40155513|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40153090|Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40153090|Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|119|40173243|Female|Tumors of Cranial and Spinal Nerves|2016|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40173243|Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|190|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.2|3.0|Malignant|1208|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|197|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1148|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|200|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1159|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|230|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.2|3.1|Malignant|1233|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|227|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1232|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.9|3.2|3.0
0-19|0.5|0.6|0.5|Benign/Borderline|214|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1211|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.2|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|232|40632786|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|2.8|3.2|3.0|Malignant|1221|40632786|Female|Tumors of Neuroepthelial Tissue|2010|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|244|40460864|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1266|40460864|Female|Tumors of Neuroepthelial Tissue|2011|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|255|40307649|Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.6
0-19|2.7|3.1|2.9|Malignant|1167|40307649|Female|Tumors of Neuroepthelial Tissue|2012|2.7|3.1|2.9
0-19|0.6|0.7|0.6|Benign/Borderline|1276|201002181|Female|Tumors of Neuroepthelial Tissue|2012-2016|0.6|0.7|0.6
0-19|2.9|3.1|3.0|Malignant|6012|201002181|Female|Tumors of Neuroepthelial Tissue|2012-2016|2.9|3.1|3.0
0-19|0.6|0.7|0.6|Benign/Borderline|259|40212686|Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1254|40212686|Female|Tumors of Neuroepthelial Tissue|2013|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|243|40155513|Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.7|0.6
0-19|3.0|3.4|3.2|Malignant|1285|40155513|Female|Tumors of Neuroepthelial Tissue|2014|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|248|40153090|Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.7|0.6
0-19|2.7|3.1|2.9|Malignant|1168|40153090|Female|Tumors of Neuroepthelial Tissue|2015|2.7|3.1|2.9
0-19|0.6|0.8|0.7|Benign/Borderline|271|40173243|Female|Tumors of Neuroepthelial Tissue|2016|0.6|0.8|0.7
0-19|2.7|3.0|2.8|Malignant|1138|40173243|Female|Tumors of Neuroepthelial Tissue|2016|2.7|3.0|2.8
0-19|0.8|1.0|0.9|Benign/Borderline|352|39865121|Female|Tumors of Sellar Region|2004|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|382|39998876|Female|Tumors of Sellar Region|2005|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|426|40165421|Female|Tumors of Sellar Region|2006|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|429|40382360|Female|Tumors of Sellar Region|2007|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|460|40576293|Female|Tumors of Sellar Region|2008|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.1|1.3|1.2|Benign/Borderline|481|40670476|Female|Tumors of Sellar Region|2009|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|542|40632786|Female|Tumors of Sellar Region|2010|1.2|1.5|1.3
0-19|~|~|~|Malignant|~|40632786|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|540|40460864|Female|Tumors of Sellar Region|2011|1.2|1.5|1.3
0-19|~|~|~|Malignant|~|40460864|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|556|40307649|Female|Tumors of Sellar Region|2012|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40307649|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.3|1.4|1.4|Benign/Borderline|2779|201002181|Female|Tumors of Sellar Region|2012-2016|1.3|1.4|1.4
0-19|~|~|~|Malignant|~|201002181|Female|Tumors of Sellar Region|2012-2016|~|~|~
0-19|1.2|1.5|1.3|Benign/Borderline|543|40212686|Female|Tumors of Sellar Region|2013|1.2|1.5|1.4
0-19|~|~|~|Malignant|~|40212686|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|578|40155513|Female|Tumors of Sellar Region|2014|1.3|1.6|1.4
0-19|~|~|~|Malignant|~|40155513|Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.2|1.5|1.3|Benign/Borderline|545|40153090|Female|Tumors of Sellar Region|2015|1.2|1.5|1.4
0-19|~|~|~|Malignant|~|40153090|Female|Tumors of Sellar Region|2015|~|~|~
0-19|1.3|1.5|1.4|Benign/Borderline|557|40173243|Female|Tumors of Sellar Region|2016|1.3|1.5|1.4
0-19|~|~|~|Malignant|~|40173243|Female|Tumors of Sellar Region|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|110|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|90|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|101|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40632786|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40632786|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|40460864|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40460864|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|40307649|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40307649|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|667|201002181|Female|Tumors of the Meninges|2012-2016|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|49|201002181|Female|Tumors of the Meninges|2012-2016|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|134|40212686|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40212686|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40155513|Female|Tumors of the Meninges|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40155513|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40153090|Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40153090|Female|Tumors of the Meninges|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|40173243|Female|Tumors of the Meninges|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40173243|Female|Tumors of the Meninges|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|47|39865121|Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|80|39998876|Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|86|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|81|40382360|Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|121|40576293|Female|Unclassified Tumors|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|130|40632786|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40632786|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|40460864|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|20|40460864|Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|135|40307649|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40307649|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|650|201002181|Female|Unclassified Tumors|2012-2016|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|115|201002181|Female|Unclassified Tumors|2012-2016|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|131|40212686|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40212686|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|140|40155513|Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40155513|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|148|40153090|Female|Unclassified Tumors|2015|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|17|40153090|Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|96|40173243|Female|Unclassified Tumors|2016|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|26|40173243|Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|25|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|40632786|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40632786|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40460864|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|22|40460864|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|33|40307649|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40307649|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|140|201002181|Female|Unique astrocytoma variants|2012-2016|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|96|201002181|Female|Unique astrocytoma variants|2012-2016|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|34|40212686|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40212686|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|38|40155513|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40155513|Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|17|40153090|Female|Unique astrocytoma variants|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|25|40153090|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40173243|Female|Unique astrocytoma variants|2016|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|20|40173243|Female|Unique astrocytoma variants|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42369153|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42179648|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42179648|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|210078173|Male|All other|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|45|210078173|Male|All other|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|All other|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|All other|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|55|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42549184|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42369153|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42179648|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Anaplastic astrocytoma|2012-2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|233|210078173|Male|Anaplastic astrocytoma|2012-2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|42040175|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|58|41960558|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|46|41943368|Male|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|41|41954424|Male|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42369153|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42179648|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Anaplastic oligodendroglioma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|210078173|Male|Anaplastic oligodendroglioma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|123|42549184|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|42369153|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42179648|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Astrocytoma, NOS|2012-2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|463|210078173|Male|Astrocytoma, NOS|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|42040175|Male|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41960558|Male|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|41943368|Male|Astrocytoma, NOS|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|41954424|Male|Astrocytoma, NOS|2016|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|39|42549184|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|42549184|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42369153|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42369153|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42179648|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42179648|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|179|210078173|Male|Choroid plexus|2012-2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|53|210078173|Male|Choroid plexus|2012-2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|42040175|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42040175|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|41960558|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41960558|Male|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41943368|Male|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|18|41943368|Male|Choroid plexus|2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|34|41954424|Male|Choroid plexus|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41954424|Male|Choroid plexus|2016|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|41889233|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|42367071|Male|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42609915|Male|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|82|42549184|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42549184|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|42369153|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42369153|Male|Craniopharyngioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|79|42179648|Male|Craniopharyngioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42179648|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|441|210078173|Male|Craniopharyngioma|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|210078173|Male|Craniopharyngioma|2012-2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|42040175|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42040175|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|105|41960558|Male|Craniopharyngioma|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41960558|Male|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|41943368|Male|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41943368|Male|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|72|41954424|Male|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41954424|Male|Craniopharyngioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42369153|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42179648|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Diffuse astrocytoma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|41|210078173|Male|Diffuse astrocytoma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|280|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|296|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|322|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|313|42549184|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|301|42369153|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|287|42179648|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Embryonal/primitive/medulloblastoma|2012-2016|~|~|~
0-19|0.6|0.7|0.7|Malignant|1417|210078173|Male|Embryonal/primitive/medulloblastoma|2012-2016|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.7|Malignant|273|42040175|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.7|Malignant|278|41960558|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|295|41943368|Male|Embryonal/primitive/medulloblastoma|2015|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.6|0.8|0.7|Malignant|284|41954424|Male|Embryonal/primitive/medulloblastoma|2016|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42549184|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549184|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42369153|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42369153|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42179648|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42179648|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|83|210078173|Male|Ependymoma variants|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|210078173|Male|Ependymoma variants|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42040175|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42040175|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Ependymoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41943368|Male|Ependymoma variants|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41943368|Male|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|41954424|Male|Ependymoma variants|2016|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41954424|Male|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42549184|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|116|42369153|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42179648|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Ependymoma/anaplastic ependymoma|2012-2016|~|~|~
0-19|0.2|0.3|0.3|Malignant|544|210078173|Male|Ependymoma/anaplastic ependymoma|2012-2016|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|42040175|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41960558|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41943368|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|41954424|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|23|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|99|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|27|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|21|42549184|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|112|42549184|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|100|42369153|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|23|42179648|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42179648|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|120|210078173|Male|Germ Cell Tumors|2012-2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|534|210078173|Male|Germ Cell Tumors|2012-2016|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|42040175|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42040175|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41960558|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|103|41960558|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|41943368|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|105|41943368|Male|Germ Cell Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|29|41954424|Male|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|106|41954424|Male|Germ Cell Tumors|2016|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42549184|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|84|42369153|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|79|42179648|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Glioblastoma|2012-2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|411|210078173|Male|Glioblastoma|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|42040175|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|77|41960558|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41943368|Male|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Glioblastoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41954424|Male|Glioblastoma|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|222|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|243|42158997|Male|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|244|42367071|Male|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|269|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|272|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.8|0.7|Malignant|283|42549184|Male|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.7|0.7|Malignant|279|42369153|Male|Glioma malignant, NOS|2011|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|42179648|Male|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|278|42179648|Male|Glioma malignant, NOS|2012|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|99|210078173|Male|Glioma malignant, NOS|2012-2016|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|1386|210078173|Male|Glioma malignant, NOS|2012-2016|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|42040175|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|269|42040175|Male|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|19|41960558|Male|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.5|0.7|0.6|Malignant|258|41960558|Male|Glioma malignant, NOS|2014|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|18|41943368|Male|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|298|41943368|Male|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|28|41954424|Male|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.6|0.8|0.7|Malignant|283|41954424|Male|Glioma malignant, NOS|2016|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|23|42369153|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42369153|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42179648|Male|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42179648|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|92|210078173|Male|Hemangioblastoma|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|210078173|Male|Hemangioblastoma|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42040175|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42040175|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|41960558|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41960558|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41943368|Male|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41943368|Male|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41954424|Male|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41954424|Male|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42549184|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549184|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|42369153|Male|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42369153|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|42179648|Male|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42179648|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|304|210078173|Male|Hemangioma|2012-2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|210078173|Male|Hemangioma|2012-2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|57|42040175|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42040175|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|41960558|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41960558|Male|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|41943368|Male|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41943368|Male|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41954424|Male|Hemangioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41954424|Male|Hemangioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42369153|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42179648|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Local Extensions from Regional Tumors|2012-2016|~|~|~
0-19|~|~|~|Malignant|~|210078173|Male|Local Extensions from Regional Tumors|2012-2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42369153|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42179648|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Lymphomas and Hematopoietic Neoplasms|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|50|210078173|Male|Lymphomas and Hematopoietic Neoplasms|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42549184|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42549184|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|42369153|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42369153|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42179648|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42179648|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|289|210078173|Male|Meningioma|2012-2016|0.1|0.2|0.1
0-19|0.0|0.0|0.0|Malignant|16|210078173|Male|Meningioma|2012-2016|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|55|42040175|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42040175|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|41960558|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41960558|Male|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|41943368|Male|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41943368|Male|Meningioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|41954424|Male|Meningioma|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41954424|Male|Meningioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42549184|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42369153|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42179648|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Mixed glioma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|44|210078173|Male|Mixed glioma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|Mixed glioma|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|57|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|52|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|63|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|47|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|86|42609915|Male|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|79|42549184|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42549184|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|42369153|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42369153|Male|Neoplasm, unspecified|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|60|42179648|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|29|42179648|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|321|210078173|Male|Neoplasm, unspecified|2012-2016|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|117|210078173|Male|Neoplasm, unspecified|2012-2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|67|42040175|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|18|42040175|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|72|41960558|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|41960558|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|57|41943368|Male|Neoplasm, unspecified|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|22|41943368|Male|Neoplasm, unspecified|2015|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|65|41954424|Male|Neoplasm, unspecified|2016|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|41954424|Male|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|127|41889233|Male|Nerve sheath, benign and malignant|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|123|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|172|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|158|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|145|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42549184|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549184|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42369153|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42369153|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42179648|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42179648|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|752|210078173|Male|Nerve sheath, benign and malignant|2012-2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|210078173|Male|Nerve sheath, benign and malignant|2012-2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|42040175|Male|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42040175|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|41960558|Male|Nerve sheath, benign and malignant|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41960558|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|41943368|Male|Nerve sheath, benign and malignant|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41943368|Male|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|164|41954424|Male|Nerve sheath, benign and malignant|2016|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41954424|Male|Nerve sheath, benign and malignant|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42369153|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42179648|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Neuroepithelial|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|210078173|Male|Neuroepithelial|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41960558|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|41943368|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|41954424|Male|Neuroepithelial|2016|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|149|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|158|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|172|42367071|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|176|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|173|42549184|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42549184|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|188|42369153|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|20|42369153|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.6|0.5|Benign/Borderline|206|42179648|Male|Neuronal/glial, neuronal|2012|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|19|42179648|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|1000|210078173|Male|Neuronal/glial, neuronal|2012-2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|122|210078173|Male|Neuronal/glial, neuronal|2012-2016|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|189|42040175|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|42040175|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|171|41960558|Male|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|41960558|Male|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|212|41943368|Male|Neuronal/glial, neuronal|2015|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|24|41943368|Male|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|0.5|0.6|0.5|Benign/Borderline|222|41954424|Male|Neuronal/glial, neuronal|2016|0.5|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|26|41954424|Male|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42549184|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42369153|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42179648|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Oligodendroglioma|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|98|210078173|Male|Oligodendroglioma|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42040175|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41960558|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41943368|Male|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|41954424|Male|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42549184|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42549184|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42369153|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42369153|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|43|42179648|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42179648|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|188|210078173|Male|Other mesenchymal|2012-2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|41|210078173|Male|Other mesenchymal|2012-2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|34|42040175|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42040175|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41960558|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41960558|Male|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|41943368|Male|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41943368|Male|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|46|41954424|Male|Other mesenchymal|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41954424|Male|Other mesenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|371|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|352|42006384|Male|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|355|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|348|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|390|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|366|42609915|Male|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|375|42549184|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|395|42369153|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|418|42179648|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Pilocytic astrocytoma|2012-2016|~|~|~
0-19|0.9|1.0|0.9|Malignant|1961|210078173|Male|Pilocytic astrocytoma|2012-2016|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|427|42040175|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|371|41960558|Male|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|372|41943368|Male|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|1.0|0.9|Malignant|373|41954424|Male|Pilocytic astrocytoma|2016|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42549184|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42549184|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42369153|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42369153|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42179648|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42179648|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210078173|Male|Pineal parenchymal|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|102|210078173|Male|Pineal parenchymal|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42040175|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|42040175|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41960558|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41960558|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41943368|Male|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41943368|Male|Pineal parenchymal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41954424|Male|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|41954424|Male|Pineal parenchymal|2016|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|86|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|118|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|132|42541971|Male|Pituitary|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|155|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|138|42549184|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549184|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|149|42369153|Male|Pituitary|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42369153|Male|Pituitary|2011|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|170|42179648|Male|Pituitary|2012|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42179648|Male|Pituitary|2012|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|855|210078173|Male|Pituitary|2012-2016|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|210078173|Male|Pituitary|2012-2016|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|167|42040175|Male|Pituitary|2013|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42040175|Male|Pituitary|2013|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|192|41960558|Male|Pituitary|2014|0.4|0.5|0.5
0-19|~|~|~|Malignant|~|41960558|Male|Pituitary|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|153|41943368|Male|Pituitary|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|41943368|Male|Pituitary|2015|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|173|41954424|Male|Pituitary|2016|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41954424|Male|Pituitary|2016|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|681|41889233|Male|Total|2004|1.5|1.8|1.6
0-19|3.4|3.8|3.6|Malignant|1505|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.8|Benign/Borderline|780|42006384|Male|Total|2005|1.7|2.0|1.9
0-19|3.2|3.6|3.4|Malignant|1430|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.8|2.0|1.9|Benign/Borderline|804|42158997|Male|Total|2006|1.8|2.0|1.9
0-19|3.4|3.8|3.6|Malignant|1505|42158997|Male|Total|2006|3.4|3.8|3.6
0-19|1.8|2.1|2.0|Benign/Borderline|839|42367071|Male|Total|2007|1.8|2.1|2.0
0-19|3.4|3.8|3.6|Malignant|1520|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.9|2.1|2.0|Benign/Borderline|850|42541971|Male|Total|2008|1.9|2.1|2.0
0-19|3.6|4.0|3.8|Malignant|1598|42541971|Male|Total|2008|3.6|3.9|3.8
0-19|2.0|2.3|2.2|Benign/Borderline|930|42609915|Male|Total|2009|2.0|2.3|2.2
0-19|3.5|3.8|3.7|Malignant|1554|42609915|Male|Total|2009|3.5|3.8|3.6
0-19|1.9|2.2|2.1|Benign/Borderline|886|42549184|Male|Total|2010|1.9|2.2|2.1
0-19|3.6|4.0|3.8|Malignant|1601|42549184|Male|Total|2010|3.6|4.0|3.8
0-19|2.1|2.3|2.2|Benign/Borderline|937|42369153|Male|Total|2011|2.1|2.4|2.2
0-19|3.6|3.9|3.8|Malignant|1588|42369153|Male|Total|2011|3.6|3.9|3.7
0-19|2.2|2.5|2.3|Benign/Borderline|994|42179648|Male|Total|2012|2.2|2.5|2.4
0-19|3.6|4.0|3.8|Malignant|1607|42179648|Male|Total|2012|3.6|4.0|3.8
0-19|2.3|2.4|2.3|Benign/Borderline|4922|210078173|Male|Total|2012-2016|2.3|2.4|2.3
0-19|3.6|3.8|3.7|Malignant|7829|210078173|Male|Total|2012-2016|3.6|3.8|3.7
0-19|2.1|2.4|2.3|Benign/Borderline|962|42040175|Male|Total|2013|2.1|2.4|2.3
0-19|3.6|4.0|3.8|Malignant|1580|42040175|Male|Total|2013|3.6|3.9|3.8
0-19|2.2|2.5|2.3|Benign/Borderline|986|41960558|Male|Total|2014|2.2|2.5|2.3
0-19|3.5|3.9|3.7|Malignant|1542|41960558|Male|Total|2014|3.5|3.9|3.7
0-19|2.1|2.4|2.3|Benign/Borderline|952|41943368|Male|Total|2015|2.1|2.4|2.3
0-19|3.6|3.9|3.8|Malignant|1575|41943368|Male|Total|2015|3.6|3.9|3.8
0-19|2.3|2.6|2.4|Benign/Borderline|1028|41954424|Male|Total|2016|2.3|2.6|2.5
0-19|3.5|3.8|3.6|Malignant|1525|41954424|Male|Total|2016|3.5|3.8|3.6
0-19|0.3|0.4|0.3|Benign/Borderline|127|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|123|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|172|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|158|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|145|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42549184|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42549184|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|140|42369153|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42369153|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42179648|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42179648|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|755|210078173|Male|Tumors of Cranial and Spinal Nerves|2012-2016|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|210078173|Male|Tumors of Cranial and Spinal Nerves|2012-2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|147|42040175|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42040175|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|144|41960558|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41960558|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|41943368|Male|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41943368|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|164|41954424|Male|Tumors of Cranial and Spinal Nerves|2016|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41954424|Male|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|230|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.5|3.3|Malignant|1363|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.3
0-19|0.5|0.7|0.6|Benign/Borderline|260|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1295|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|260|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1357|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|265|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|1373|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|278|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1435|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.6|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|271|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1409|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|280|42549184|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1445|42549184|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|303|42369153|Male|Tumors of Neuroepthelial Tissue|2011|0.6|0.8|0.7
0-19|3.3|3.6|3.4|Malignant|1452|42369153|Male|Tumors of Neuroepthelial Tissue|2011|3.3|3.6|3.4
0-19|0.7|0.8|0.8|Benign/Borderline|318|42179648|Male|Tumors of Neuroepthelial Tissue|2012|0.7|0.8|0.8
0-19|3.2|3.6|3.4|Malignant|1439|42179648|Male|Tumors of Neuroepthelial Tissue|2012|3.2|3.6|3.4
0-19|0.7|0.8|0.7|Benign/Borderline|1555|210078173|Male|Tumors of Neuroepthelial Tissue|2012-2016|0.7|0.8|0.7
0-19|3.3|3.4|3.4|Malignant|7041|210078173|Male|Tumors of Neuroepthelial Tissue|2012-2016|3.3|3.4|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|301|42040175|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1422|42040175|Male|Tumors of Neuroepthelial Tissue|2013|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|281|41960558|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.8|0.7
0-19|3.1|3.5|3.3|Malignant|1391|41960558|Male|Tumors of Neuroepthelial Tissue|2014|3.1|3.5|3.3
0-19|0.7|0.8|0.7|Benign/Borderline|312|41943368|Male|Tumors of Neuroepthelial Tissue|2015|0.7|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1419|41943368|Male|Tumors of Neuroepthelial Tissue|2015|3.2|3.6|3.4
0-19|0.7|0.9|0.8|Benign/Borderline|343|41954424|Male|Tumors of Neuroepthelial Tissue|2016|0.7|0.9|0.8
0-19|3.1|3.4|3.3|Malignant|1370|41954424|Male|Tumors of Neuroepthelial Tissue|2016|3.1|3.4|3.3
0-19|0.3|0.5|0.4|Benign/Borderline|169|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|213|42006384|Male|Tumors of Sellar Region|2005|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|176|42158997|Male|Tumors of Sellar Region|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|204|42367071|Male|Tumors of Sellar Region|2007|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|228|42541971|Male|Tumors of Sellar Region|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|236|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|220|42549184|Male|Tumors of Sellar Region|2010|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42549184|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|219|42369153|Male|Tumors of Sellar Region|2011|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42369153|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|249|42179648|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42179648|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.6|0.6|0.6|Benign/Borderline|1296|210078173|Male|Tumors of Sellar Region|2012-2016|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|210078173|Male|Tumors of Sellar Region|2012-2016|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|258|42040175|Male|Tumors of Sellar Region|2013|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42040175|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|297|41960558|Male|Tumors of Sellar Region|2014|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41960558|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|247|41943368|Male|Tumors of Sellar Region|2015|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41943368|Male|Tumors of Sellar Region|2015|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|245|41954424|Male|Tumors of Sellar Region|2016|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|41954424|Male|Tumors of Sellar Region|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|83|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|80|42367071|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42549184|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42549184|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|124|42369153|Male|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42369153|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|126|42179648|Male|Tumors of the Meninges|2012|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42179648|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|569|210078173|Male|Tumors of the Meninges|2012-2016|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|57|210078173|Male|Tumors of the Meninges|2012-2016|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|106|42040175|Male|Tumors of the Meninges|2013|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42040175|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|41960558|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41960558|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|119|41943368|Male|Tumors of the Meninges|2015|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41943368|Male|Tumors of the Meninges|2015|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|106|41954424|Male|Tumors of the Meninges|2016|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41954424|Male|Tumors of the Meninges|2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|76|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|86|42158997|Male|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|90|42541971|Male|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|146|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|42549184|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|18|42549184|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|136|42369153|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|16|42369153|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|124|42179648|Male|Unclassified Tumors|2012|0.2|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|42179648|Male|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|627|210078173|Male|Unclassified Tumors|2012-2016|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|124|210078173|Male|Unclassified Tumors|2012-2016|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|124|42040175|Male|Unclassified Tumors|2013|0.2|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|20|42040175|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|127|41960558|Male|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|41960558|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|111|41943368|Male|Unclassified Tumors|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|23|41943368|Male|Unclassified Tumors|2015|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|141|41954424|Male|Unclassified Tumors|2016|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|41954424|Male|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|40|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|42549184|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|42549184|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|42|42369153|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|28|42369153|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|38|42179648|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42179648|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|173|210078173|Male|Unique astrocytoma variants|2012-2016|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|128|210078173|Male|Unique astrocytoma variants|2012-2016|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|36|42040175|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42040175|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|43|41960558|Male|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41960558|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|26|41943368|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|41943368|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|30|41954424|Male|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|41954424|Male|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83181970|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82830017|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82487297|Male and Female|All other|2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|31|411080354|Male and Female|All other|2012-2016|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|77|411080354|Male and Female|All other|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82252861|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82096458|Male and Female|All other|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|All other|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82127667|Male and Female|All other|2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|86|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83181970|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82830017|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82487297|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Anaplastic astrocytoma|2012-2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|410|411080354|Male and Female|Anaplastic astrocytoma|2012-2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|95|82252861|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|98|82116071|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|79|82096458|Male and Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Anaplastic astrocytoma|2016|~|~|~
0-19|0.1|0.1|0.1|Malignant|71|82127667|Male and Female|Anaplastic astrocytoma|2016|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83181970|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82830017|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82487297|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Anaplastic oligodendroglioma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|411080354|Male and Female|Anaplastic oligodendroglioma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82252861|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82096458|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82127667|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|181|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|179|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|83181970|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|184|82830017|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|165|82487297|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Astrocytoma, NOS|2012-2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|897|411080354|Male and Female|Astrocytoma, NOS|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|188|82252861|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|208|82116071|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|168|82096458|Male and Female|Astrocytoma, NOS|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Astrocytoma, NOS|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|168|82127667|Male and Female|Astrocytoma, NOS|2016|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|55|82005260|Male and Female|Choroid plexus|2005|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|68|83181970|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|23|83181970|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82830017|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82830017|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|62|82487297|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|18|82487297|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|306|411080354|Male and Female|Choroid plexus|2012-2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|105|411080354|Male and Female|Choroid plexus|2012-2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82252861|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82252861|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82116071|Male and Female|Choroid plexus|2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|28|82116071|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82096458|Male and Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|82096458|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|57|82127667|Male and Female|Choroid plexus|2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82127667|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|166|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|182|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|160|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|174|83181970|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83181970|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|82830017|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82830017|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|82487297|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82487297|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|844|411080354|Male and Female|Craniopharyngioma|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|411080354|Male and Female|Craniopharyngioma|2012-2016|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|180|82252861|Male and Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82252861|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|197|82116071|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82116071|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|174|82096458|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82096458|Male and Female|Craniopharyngioma|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|136|82127667|Male and Female|Craniopharyngioma|2016|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82127667|Male and Female|Craniopharyngioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83181970|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82830017|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82487297|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Diffuse astrocytoma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|69|411080354|Male and Female|Diffuse astrocytoma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|82252861|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|82096458|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Malignant|~|82127667|Male and Female|Diffuse astrocytoma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|508|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|465|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|499|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|519|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|551|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|487|83181970|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|497|82830017|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|467|82487297|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Embryonal/primitive/medulloblastoma|2012-2016|~|~|~
0-19|0.6|0.6|0.6|Malignant|2360|411080354|Male and Female|Embryonal/primitive/medulloblastoma|2012-2016|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82252861|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.7|0.6|Malignant|489|82116071|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.5|0.6|0.6|Malignant|484|82096458|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
0-19|0.5|0.6|0.6|Malignant|460|82127667|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83181970|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83181970|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82830017|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82830017|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82487297|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82487297|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|151|411080354|Male and Female|Ependymoma variants|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|411080354|Male and Female|Ependymoma variants|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82252861|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82252861|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82096458|Male and Female|Ependymoma variants|2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82096458|Male and Female|Ependymoma variants|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82127667|Male and Female|Ependymoma variants|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82127667|Male and Female|Ependymoma variants|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|213|83181970|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|215|82830017|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|82487297|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Ependymoma/anaplastic ependymoma|2012-2016|~|~|~
0-19|0.2|0.3|0.2|Malignant|975|411080354|Male and Female|Ependymoma/anaplastic ependymoma|2012-2016|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|201|82252861|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|196|82116071|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|199|82096458|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|176|82127667|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|32|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|146|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|46|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|41|83181970|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|165|83181970|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82830017|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|138|82830017|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|38|82487297|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|131|82487297|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|218|411080354|Male and Female|Germ Cell Tumors|2012-2016|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|738|411080354|Male and Female|Germ Cell Tumors|2012-2016|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|45|82252861|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|157|82252861|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|82116071|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|137|82116071|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82096458|Male and Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|150|82096458|Male and Female|Germ Cell Tumors|2015|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|52|82127667|Male and Female|Germ Cell Tumors|2016|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|163|82127667|Male and Female|Germ Cell Tumors|2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|112|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|128|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|121|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|119|83181970|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|159|82830017|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|153|82487297|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Glioblastoma|2012-2016|~|~|~
0-19|0.2|0.2|0.2|Malignant|746|411080354|Male and Female|Glioblastoma|2012-2016|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|162|82252861|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|144|82116071|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|150|82096458|Male and Female|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Glioblastoma|2016|~|~|~
0-19|0.1|0.2|0.2|Malignant|137|82127667|Male and Female|Glioblastoma|2016|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|462|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|489|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|511|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|550|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|568|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|20|83181970|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|547|83181970|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|31|82830017|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.8|0.7|Malignant|586|82830017|Male and Female|Glioma malignant, NOS|2011|0.7|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|35|82487297|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|507|82487297|Male and Female|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|181|411080354|Male and Female|Glioma malignant, NOS|2012-2016|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|2735|411080354|Male and Female|Glioma malignant, NOS|2012-2016|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|30|82252861|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|563|82252861|Male and Female|Glioma malignant, NOS|2013|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|34|82116071|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|521|82116071|Male and Female|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|33|82096458|Male and Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|560|82096458|Male and Female|Glioma malignant, NOS|2015|0.6|0.7|0.7
0-19|0.0|0.1|0.1|Benign/Borderline|49|82127667|Male and Female|Glioma malignant, NOS|2016|0.0|0.1|0.1
0-19|0.7|0.8|0.7|Malignant|584|82127667|Male and Female|Glioma malignant, NOS|2016|0.7|0.8|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|23|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|30|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|83181970|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83181970|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82830017|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82830017|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|36|82487297|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82487297|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|192|411080354|Male and Female|Hemangioblastoma|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|411080354|Male and Female|Hemangioblastoma|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82252861|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82252861|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|50|82116071|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82116071|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|82096458|Male and Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82096458|Male and Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82127667|Male and Female|Hemangioblastoma|2016|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82127667|Male and Female|Hemangioblastoma|2016|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|45|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|69|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|81|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|85|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|111|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|83181970|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83181970|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82830017|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82830017|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|129|82487297|Male and Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82487297|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|605|411080354|Male and Female|Hemangioma|2012-2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|411080354|Male and Female|Hemangioma|2012-2016|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|116|82252861|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82252861|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|118|82116071|Male and Female|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82116071|Male and Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|120|82096458|Male and Female|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82096458|Male and Female|Hemangioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|122|82127667|Male and Female|Hemangioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82127667|Male and Female|Hemangioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83181970|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82830017|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82487297|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Local Extensions from Regional Tumors|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|20|411080354|Male and Female|Local Extensions from Regional Tumors|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82252861|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|82096458|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Malignant|~|82127667|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83181970|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82830017|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82487297|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|75|411080354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82252861|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82096458|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|82127667|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|100|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|107|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|116|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|118|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|83181970|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83181970|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|134|82830017|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82830017|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|125|82487297|Male and Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82487297|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|625|411080354|Male and Female|Meningioma|2012-2016|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|37|411080354|Male and Female|Meningioma|2012-2016|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|131|82252861|Male and Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82252861|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|126|82116071|Male and Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82116071|Male and Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|137|82096458|Male and Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82096458|Male and Female|Meningioma|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|106|82127667|Male and Female|Meningioma|2016|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82127667|Male and Female|Meningioma|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|83181970|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82830017|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82487297|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Mixed glioma|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|84|411080354|Male and Female|Mixed glioma|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82252861|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82116071|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82096458|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Mixed glioma|2016|~|~|~
0-19|~|~|~|Malignant|~|82127667|Male and Female|Mixed glioma|2016|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|113|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|103|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|115|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|126|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|148|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|166|83181970|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83181970|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|136|82830017|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|35|82830017|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|130|82487297|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|53|82487297|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|669|411080354|Male and Female|Neoplasm, unspecified|2012-2016|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|227|411080354|Male and Female|Neoplasm, unspecified|2012-2016|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|138|82252861|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|41|82252861|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|149|82116071|Male and Female|Neoplasm, unspecified|2014|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82116071|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|137|82096458|Male and Female|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|82096458|Male and Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|115|82127667|Male and Female|Neoplasm, unspecified|2016|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|48|82127667|Male and Female|Neoplasm, unspecified|2016|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|241|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|285|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|327|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|286|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|288|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|308|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|83181970|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181970|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|271|82830017|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82830017|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|292|82487297|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82487297|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|1403|411080354|Male and Female|Nerve sheath, benign and malignant|2012-2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|411080354|Male and Female|Nerve sheath, benign and malignant|2012-2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|286|82252861|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82252861|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|242|82116071|Male and Female|Nerve sheath, benign and malignant|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82116071|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|300|82096458|Male and Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82096458|Male and Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|283|82127667|Male and Female|Nerve sheath, benign and malignant|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82127667|Male and Female|Nerve sheath, benign and malignant|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83181970|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82830017|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82487297|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Neuroepithelial|2012-2016|~|~|~
0-19|0.0|0.0|0.0|Malignant|50|411080354|Male and Female|Neuroepithelial|2012-2016|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82252861|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82116071|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|82096458|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Neuroepithelial|2016|~|~|~
0-19|~|~|~|Malignant|~|82127667|Male and Female|Neuroepithelial|2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|264|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|296|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|55|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|279|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|310|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|309|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|297|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|317|83181970|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83181970|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|340|82830017|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|34|82830017|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|361|82487297|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|35|82487297|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|1824|411080354|Male and Female|Neuronal/glial, neuronal|2012-2016|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|230|411080354|Male and Female|Neuronal/glial, neuronal|2012-2016|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|349|82252861|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|46|82252861|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|328|82116071|Male and Female|Neuronal/glial, neuronal|2014|0.4|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|55|82116071|Male and Female|Neuronal/glial, neuronal|2014|0.1|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|380|82096458|Male and Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|40|82096458|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|406|82127667|Male and Female|Neuronal/glial, neuronal|2016|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|54|82127667|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|50|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|45|83181970|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82830017|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|82487297|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Oligodendroglioma|2012-2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|194|411080354|Male and Female|Oligodendroglioma|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82252861|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82116071|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|36|82096458|Male and Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Oligodendroglioma|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82127667|Male and Female|Oligodendroglioma|2016|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|82749431|Male and Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|49|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|50|83181970|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83181970|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|60|82830017|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82830017|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|94|82487297|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|82487297|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|419|411080354|Male and Female|Other mesenchymal|2012-2016|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|67|411080354|Male and Female|Other mesenchymal|2012-2016|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|74|82252861|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82252861|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|72|82116071|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82116071|Male and Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|83|82096458|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82096458|Male and Female|Other mesenchymal|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|96|82127667|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82127667|Male and Female|Other mesenchymal|2016|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|700|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|674|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|672|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|682|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|725|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|716|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|767|83181970|Male and Female|Pilocytic astrocytoma|2010|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|751|82830017|Male and Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|1.0|Malignant|792|82487297|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|411080354|Male and Female|Pilocytic astrocytoma|2012-2016|~|~|~
0-19|0.9|0.9|0.9|Malignant|3756|411080354|Male and Female|Pilocytic astrocytoma|2012-2016|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|1.0|Malignant|789|82252861|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|1.0
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|0.9|Malignant|768|82116071|Male and Female|Pilocytic astrocytoma|2014|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|0.9|0.9|Malignant|719|82096458|Male and Female|Pilocytic astrocytoma|2015|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Pilocytic astrocytoma|2016|~|~|~
0-19|0.8|0.9|0.8|Malignant|688|82127667|Male and Female|Pilocytic astrocytoma|2016|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83181970|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83181970|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82830017|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82830017|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82487297|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82487297|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|38|411080354|Male and Female|Pineal parenchymal|2012-2016|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|183|411080354|Male and Female|Pineal parenchymal|2012-2016|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82252861|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|82252861|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82116071|Male and Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|39|82116071|Male and Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82096458|Male and Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|82096458|Male and Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82127667|Male and Female|Pineal parenchymal|2016|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82127667|Male and Female|Pineal parenchymal|2016|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|355|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|423|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|445|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|451|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|528|83118264|Male and Female|Pituitary|2008|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|545|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|588|83181970|Male and Female|Pituitary|2010|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|83181970|Male and Female|Pituitary|2010|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|603|82830017|Male and Female|Pituitary|2011|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82830017|Male and Female|Pituitary|2011|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|648|82487297|Male and Female|Pituitary|2012|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82487297|Male and Female|Pituitary|2012|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|3231|411080354|Male and Female|Pituitary|2012-2016|0.8|0.8|0.8
0-19|~|~|~|Malignant|~|411080354|Male and Female|Pituitary|2012-2016|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|621|82252861|Male and Female|Pituitary|2013|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82252861|Male and Female|Pituitary|2013|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|678|82116071|Male and Female|Pituitary|2014|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82116071|Male and Female|Pituitary|2014|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|618|82096458|Male and Female|Pituitary|2015|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82096458|Male and Female|Pituitary|2015|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|666|82127667|Male and Female|Pituitary|2016|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|82127667|Male and Female|Pituitary|2016|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|1467|81754354|Male and Female|Total|2004|1.7|1.9|1.8
0-19|3.3|3.6|3.5|Malignant|2811|81754354|Male and Female|Total|2004|3.3|3.6|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1725|82005260|Male and Female|Total|2005|2.0|2.2|2.1
0-19|3.1|3.4|3.3|Malignant|2668|82005260|Male and Female|Total|2005|3.1|3.4|3.3
0-19|2.0|2.2|2.1|Benign/Borderline|1764|82324418|Male and Female|Total|2006|2.0|2.2|2.1
0-19|3.2|3.5|3.3|Malignant|2734|82324418|Male and Female|Total|2006|3.2|3.4|3.3
0-19|2.1|2.3|2.2|Benign/Borderline|1816|82749431|Male and Female|Total|2007|2.1|2.3|2.2
0-19|3.3|3.5|3.4|Malignant|2816|82749431|Male and Female|Total|2007|3.3|3.5|3.4
0-19|2.2|2.4|2.3|Benign/Borderline|1910|83118264|Male and Female|Total|2008|2.2|2.4|2.3
0-19|3.4|3.6|3.5|Malignant|2885|83118264|Male and Female|Total|2008|3.3|3.6|3.5
0-19|2.3|2.5|2.4|Benign/Borderline|2012|83280391|Male and Female|Total|2009|2.3|2.5|2.4
0-19|3.3|3.6|3.4|Malignant|2846|83280391|Male and Female|Total|2009|3.3|3.5|3.4
0-19|2.3|2.5|2.4|Benign/Borderline|2035|83181970|Male and Female|Total|2010|2.3|2.6|2.4
0-19|3.4|3.6|3.5|Malignant|2903|83181970|Male and Female|Total|2010|3.4|3.6|3.5
0-19|2.4|2.6|2.5|Benign/Borderline|2117|82830017|Male and Female|Total|2011|2.4|2.7|2.6
0-19|3.4|3.7|3.5|Malignant|2935|82830017|Male and Female|Total|2011|3.4|3.7|3.5
0-19|2.6|2.8|2.7|Benign/Borderline|2222|82487297|Male and Female|Total|2012|2.6|2.8|2.7
0-19|3.3|3.6|3.4|Malignant|2838|82487297|Male and Female|Total|2012|3.3|3.6|3.4
0-19|2.6|2.7|2.7|Benign/Borderline|11044|411080354|Male and Female|Total|2012-2016|2.6|2.7|2.7
0-19|3.4|3.5|3.5|Malignant|14254|411080354|Male and Female|Total|2012-2016|3.4|3.5|3.5
0-19|2.5|2.8|2.6|Benign/Borderline|2189|82252861|Male and Female|Total|2013|2.6|2.8|2.7
0-19|3.4|3.7|3.6|Malignant|2923|82252861|Male and Female|Total|2013|3.4|3.7|3.6
0-19|2.6|2.8|2.7|Benign/Borderline|2206|82116071|Male and Female|Total|2014|2.6|2.8|2.7
0-19|3.4|3.7|3.5|Malignant|2901|82116071|Male and Female|Total|2014|3.4|3.7|3.5
0-19|2.6|2.8|2.7|Benign/Borderline|2198|82096458|Male and Female|Total|2015|2.6|2.8|2.7
0-19|3.3|3.6|3.4|Malignant|2826|82096458|Male and Female|Total|2015|3.3|3.6|3.4
0-19|2.6|2.8|2.7|Benign/Borderline|2229|82127667|Male and Female|Total|2016|2.6|2.8|2.7
0-19|3.2|3.5|3.4|Malignant|2766|82127667|Male and Female|Total|2016|3.2|3.5|3.4
0-19|0.3|0.3|0.3|Benign/Borderline|241|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|285|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|327|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|286|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|288|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|308|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|270|83181970|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83181970|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|271|82830017|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82830017|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|292|82487297|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82487297|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|1406|411080354|Male and Female|Tumors of Cranial and Spinal Nerves|2012-2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|411080354|Male and Female|Tumors of Cranial and Spinal Nerves|2012-2016|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|287|82252861|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82252861|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|244|82116071|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82116071|Male and Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|300|82096458|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82096458|Male and Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|283|82127667|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82127667|Male and Female|Tumors of Cranial and Spinal Nerves|2016|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|420|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.2|Malignant|2571|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|457|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2443|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|460|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|3.0|3.2|3.1|Malignant|2516|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|495|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.7|0.6
0-19|3.0|3.3|3.2|Malignant|2606|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|505|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2667|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|485|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.3|3.2|Malignant|2620|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|512|83181970|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2666|83181970|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|547|82830017|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.7
0-19|3.2|3.4|3.3|Malignant|2718|82830017|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.2|3.4|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|573|82487297|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.8|0.7
0-19|3.0|3.3|3.2|Malignant|2606|82487297|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.0|3.3|3.2
0-19|0.7|0.7|0.7|Benign/Borderline|2831|411080354|Male and Female|Tumors of Neuroepthelial Tissue|2012-2016|0.7|0.7|0.7
0-19|3.1|3.2|3.2|Malignant|13053|411080354|Male and Female|Tumors of Neuroepthelial Tissue|2012-2016|3.1|3.2|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|560|82252861|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.7
0-19|3.1|3.4|3.3|Malignant|2676|82252861|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.1|3.4|3.3
0-19|0.6|0.7|0.6|Benign/Borderline|524|82116071|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|2676|82116071|Male and Female|Tumors of Neuroepthelial Tissue|2014|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|560|82096458|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.7
0-19|3.0|3.3|3.2|Malignant|2587|82096458|Male and Female|Tumors of Neuroepthelial Tissue|2015|3.0|3.3|3.2
0-19|0.7|0.8|0.7|Benign/Borderline|614|82127667|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.7|0.8|0.7
0-19|2.9|3.2|3.1|Malignant|2508|82127667|Male and Female|Tumors of Neuroepthelial Tissue|2016|2.9|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|521|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|595|82005260|Male and Female|Tumors of Sellar Region|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|602|82324418|Male and Female|Tumors of Sellar Region|2006|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|633|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|688|83118264|Male and Female|Tumors of Sellar Region|2008|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|717|83280391|Male and Female|Tumors of Sellar Region|2009|0.8|0.9|0.9
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|762|83181970|Male and Female|Tumors of Sellar Region|2010|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|83181970|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|759|82830017|Male and Female|Tumors of Sellar Region|2011|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|82830017|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.9|1.0|1.0|Benign/Borderline|805|82487297|Male and Female|Tumors of Sellar Region|2012|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82487297|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.0|1.0|1.0|Benign/Borderline|4075|411080354|Male and Female|Tumors of Sellar Region|2012-2016|1.0|1.0|1.0
0-19|~|~|~|Malignant|~|411080354|Male and Female|Tumors of Sellar Region|2012-2016|~|~|~
0-19|0.9|1.0|1.0|Benign/Borderline|801|82252861|Male and Female|Tumors of Sellar Region|2013|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82252861|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.0|1.1|1.1|Benign/Borderline|875|82116071|Male and Female|Tumors of Sellar Region|2014|1.0|1.1|1.1
0-19|~|~|~|Malignant|~|82116071|Male and Female|Tumors of Sellar Region|2014|~|~|~
0-19|0.9|1.0|1.0|Benign/Borderline|792|82096458|Male and Female|Tumors of Sellar Region|2015|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82096458|Male and Female|Tumors of Sellar Region|2015|~|~|~
0-19|0.9|1.0|1.0|Benign/Borderline|802|82127667|Male and Female|Tumors of Sellar Region|2016|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82127667|Male and Female|Tumors of Sellar Region|2016|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|146|81754354|Male and Female|Tumors of the Meninges|2004|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|195|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|159|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|174|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|178|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|197|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|187|83181970|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83181970|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|230|82830017|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|17|82830017|Male and Female|Tumors of the Meninges|2011|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|255|82487297|Male and Female|Tumors of the Meninges|2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|21|82487297|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1236|411080354|Male and Female|Tumors of the Meninges|2012-2016|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|106|411080354|Male and Female|Tumors of the Meninges|2012-2016|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|240|82252861|Male and Female|Tumors of the Meninges|2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|22|82252861|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|248|82116071|Male and Female|Tumors of the Meninges|2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|19|82116071|Male and Female|Tumors of the Meninges|2014|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|252|82096458|Male and Female|Tumors of the Meninges|2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|82096458|Male and Female|Tumors of the Meninges|2015|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|241|82127667|Male and Female|Tumors of the Meninges|2016|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|21|82127667|Male and Female|Tumors of the Meninges|2016|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|108|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|156|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|172|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|196|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|43|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|211|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|259|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|40|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|263|83181970|Male and Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|83181970|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|273|82830017|Male and Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|36|82830017|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|259|82487297|Male and Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|56|82487297|Male and Female|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|1277|411080354|Male and Female|Unclassified Tumors|2012-2016|0.3|0.3|0.3
0-19|0.1|0.1|0.1|Malignant|239|411080354|Male and Female|Unclassified Tumors|2012-2016|0.1|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|255|82252861|Male and Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|44|82252861|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|267|82116071|Male and Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|82116071|Male and Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|259|82096458|Male and Female|Unclassified Tumors|2015|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|40|82096458|Male and Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|237|82127667|Male and Female|Unclassified Tumors|2016|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|49|82127667|Male and Female|Unclassified Tumors|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|52|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|30|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|65|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|31|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|75|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|56|83181970|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|83181970|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|82830017|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82830017|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|71|82487297|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|82487297|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|313|411080354|Male and Female|Unique astrocytoma variants|2012-2016|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|224|411080354|Male and Female|Unique astrocytoma variants|2012-2016|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|70|82252861|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82252861|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|81|82116071|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82116071|Male and Female|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|43|82096458|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82096458|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|48|82127667|Male and Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|46|82127667|Male and Female|Unique astrocytoma variants|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|19|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|20|116622642|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|116622642|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117941206|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|117941206|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|119233275|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119233275|Female|All other|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|95|608145338|Female|All other|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|111|608145338|Female|All other|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120424999|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|22|120424999|Female|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121659593|Female|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121659593|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|122838596|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|122838596|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|123988875|Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|26|123988875|Female|All other|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|510|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|529|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|503|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|502|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116622642|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|569|116622642|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|117941206|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|569|117941206|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119233275|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|583|119233275|Female|Anaplastic astrocytoma|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|608145338|Female|Anaplastic astrocytoma|2012-2016|~|~|~
20+|0.5|0.5|0.5|Malignant|3152|608145338|Female|Anaplastic astrocytoma|2012-2016|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|120424999|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|637|120424999|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|121659593|Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|615|121659593|Female|Anaplastic astrocytoma|2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|122838596|Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|697|122838596|Female|Anaplastic astrocytoma|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|123988875|Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.4|0.5|0.5|Malignant|620|123988875|Female|Anaplastic astrocytoma|2016|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|184|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|166|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|137|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|158|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|170|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|145|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116622642|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|133|116622642|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117941206|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|154|117941206|Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119233275|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|168|119233275|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|608145338|Female|Anaplastic oligodendroglioma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|800|608145338|Female|Anaplastic oligodendroglioma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120424999|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|151|120424999|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121659593|Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|151|121659593|Female|Anaplastic oligodendroglioma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122838596|Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|163|122838596|Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|123988875|Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|167|123988875|Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|568|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|564|110320645|Female|Astrocytoma, NOS|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|539|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|534|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|493|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|480|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116622642|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|475|116622642|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117941206|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|459|117941206|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119233275|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|490|119233275|Female|Astrocytoma, NOS|2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|608145338|Female|Astrocytoma, NOS|2012-2016|~|~|~
20+|0.4|0.4|0.4|Malignant|2483|608145338|Female|Astrocytoma, NOS|2012-2016|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|120424999|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|444|120424999|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|121659593|Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.4|0.4|Malignant|484|121659593|Female|Astrocytoma, NOS|2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|122838596|Female|Astrocytoma, NOS|2015|~|~|~
20+|0.4|0.5|0.4|Malignant|510|122838596|Female|Astrocytoma, NOS|2015|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|123988875|Female|Astrocytoma, NOS|2016|~|~|~
20+|0.4|0.5|0.4|Malignant|555|123988875|Female|Astrocytoma, NOS|2016|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|49|116622642|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116622642|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|117941206|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|117941206|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|39|119233275|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119233275|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|220|608145338|Female|Choroid plexus|2012-2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|608145338|Female|Choroid plexus|2012-2016|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|120424999|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|120424999|Female|Choroid plexus|2013|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|47|121659593|Female|Choroid plexus|2014|0.0|0.1|0.0
20+|~|~|~|Malignant|~|121659593|Female|Choroid plexus|2014|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|46|122838596|Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122838596|Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|40|123988875|Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123988875|Female|Choroid plexus|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|204|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|184|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|224|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|116622642|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116622642|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|117941206|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117941206|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|119233275|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119233275|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1123|608145338|Female|Craniopharyngioma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|608145338|Female|Craniopharyngioma|2012-2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|243|120424999|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120424999|Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|121659593|Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121659593|Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|233|122838596|Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122838596|Female|Craniopharyngioma|2015|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|201|123988875|Female|Craniopharyngioma|2016|0.1|0.2|0.2
20+|~|~|~|Malignant|~|123988875|Female|Craniopharyngioma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|93|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|131|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116622642|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|116622642|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117941206|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|114|117941206|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119233275|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|94|119233275|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|608145338|Female|Diffuse astrocytoma|2012-2016|~|~|~
20+|0.0|0.0|0.0|Malignant|274|608145338|Female|Diffuse astrocytoma|2012-2016|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|120424999|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|72|120424999|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121659593|Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.0|Malignant|62|121659593|Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122838596|Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|35|122838596|Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123988875|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Malignant|~|123988875|Female|Diffuse astrocytoma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|89|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116622642|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|72|116622642|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117941206|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|69|117941206|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119233275|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|81|119233275|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|608145338|Female|Embryonal/primitive/medulloblastoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|372|608145338|Female|Embryonal/primitive/medulloblastoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120424999|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|87|120424999|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121659593|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|72|121659593|Female|Embryonal/primitive/medulloblastoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122838596|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.0|0.1|0.1|Malignant|68|122838596|Female|Embryonal/primitive/medulloblastoma|2015|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123988875|Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|64|123988875|Female|Embryonal/primitive/medulloblastoma|2016|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|121|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|148|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|116622642|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116622642|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|117941206|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117941206|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|130|119233275|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119233275|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|629|608145338|Female|Ependymoma variants|2012-2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|608145338|Female|Ependymoma variants|2012-2016|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|120424999|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|120424999|Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|131|121659593|Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|121659593|Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|131|122838596|Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|122838596|Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|119|123988875|Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|123988875|Female|Ependymoma variants|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|293|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|302|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|293|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|295|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|313|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|345|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116622642|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|296|116622642|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117941206|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|297|117941206|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119233275|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|303|119233275|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|33|608145338|Female|Ependymoma/anaplastic ependymoma|2012-2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|1345|608145338|Female|Ependymoma/anaplastic ependymoma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|120424999|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|274|120424999|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|121659593|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|242|121659593|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122838596|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.2|Malignant|270|122838596|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|123988875|Female|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.2|0.2|Malignant|256|123988875|Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|115293599|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116622642|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116622642|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|117941206|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117941206|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|119233275|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119233275|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|150|608145338|Female|Germ Cell Tumors|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|608145338|Female|Germ Cell Tumors|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|120424999|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|120424999|Female|Germ Cell Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|121659593|Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121659593|Female|Germ Cell Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|122838596|Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122838596|Female|Germ Cell Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|123988875|Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|123988875|Female|Germ Cell Tumors|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4094|109112165|Female|Glioblastoma|2004|3.6|3.9|3.8
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4160|110320645|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.5|3.7|3.6|Malignant|4290|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4368|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4407|114027722|Female|Glioblastoma|2008|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4476|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116622642|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4610|116622642|Female|Glioblastoma|2010|3.8|4.1|4.0
20+|~|~|~|Benign/Borderline|~|117941206|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4584|117941206|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|119233275|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4861|119233275|Female|Glioblastoma|2012|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|608145338|Female|Glioblastoma|2012-2016|~|~|~
20+|3.5|3.5|3.5|Malignant|24736|608145338|Female|Glioblastoma|2012-2016|4.0|4.1|4.1
20+|~|~|~|Benign/Borderline|~|120424999|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4911|120424999|Female|Glioblastoma|2013|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|121659593|Female|Glioblastoma|2014|~|~|~
20+|3.3|3.5|3.4|Malignant|4786|121659593|Female|Glioblastoma|2014|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|122838596|Female|Glioblastoma|2015|~|~|~
20+|3.5|3.7|3.6|Malignant|5102|122838596|Female|Glioblastoma|2015|4.0|4.3|4.2
20+|~|~|~|Benign/Borderline|~|123988875|Female|Glioblastoma|2016|~|~|~
20+|3.4|3.6|3.5|Malignant|5076|123988875|Female|Glioblastoma|2016|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|423|109112165|Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|392|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|397|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|412|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|442|114027722|Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|513|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116622642|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|410|116622642|Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117941206|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|446|117941206|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|119233275|Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|435|119233275|Female|Glioma malignant, NOS|2012|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|105|608145338|Female|Glioma malignant, NOS|2012-2016|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|2342|608145338|Female|Glioma malignant, NOS|2012-2016|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|120424999|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|460|120424999|Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|26|121659593|Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|439|121659593|Female|Glioma malignant, NOS|2014|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|28|122838596|Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|506|122838596|Female|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|17|123988875|Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|502|123988875|Female|Glioma malignant, NOS|2016|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|206|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|234|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|116622642|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116622642|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|245|117941206|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117941206|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|255|119233275|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119233275|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1191|608145338|Female|Hemangioblastoma|2012-2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|16|608145338|Female|Hemangioblastoma|2012-2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|230|120424999|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120424999|Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|121659593|Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121659593|Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|240|122838596|Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122838596|Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|251|123988875|Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|123988875|Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|234|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|283|110320645|Female|Hemangioma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|314|111567226|Female|Hemangioma|2006|0.3|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|366|112783993|Female|Hemangioma|2007|0.3|0.4|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|465|114027722|Female|Hemangioma|2008|0.4|0.4|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|516|115293599|Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|652|116622642|Female|Hemangioma|2010|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116622642|Female|Hemangioma|2010|~|~|~
20+|0.6|0.6|0.6|Benign/Borderline|710|117941206|Female|Hemangioma|2011|0.6|0.6|0.6
20+|~|~|~|Malignant|~|117941206|Female|Hemangioma|2011|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|704|119233275|Female|Hemangioma|2012|0.5|0.6|0.6
20+|~|~|~|Malignant|~|119233275|Female|Hemangioma|2012|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|3091|608145338|Female|Hemangioma|2012-2016|0.5|0.5|0.5
20+|~|~|~|Malignant|~|608145338|Female|Hemangioma|2012-2016|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|716|120424999|Female|Hemangioma|2013|0.6|0.6|0.6
20+|~|~|~|Malignant|~|120424999|Female|Hemangioma|2013|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|633|121659593|Female|Hemangioma|2014|0.5|0.6|0.5
20+|~|~|~|Malignant|~|121659593|Female|Hemangioma|2014|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|542|122838596|Female|Hemangioma|2015|0.4|0.5|0.4
20+|~|~|~|Malignant|~|122838596|Female|Hemangioma|2015|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|496|123988875|Female|Hemangioma|2016|0.4|0.4|0.4
20+|~|~|~|Malignant|~|123988875|Female|Hemangioma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|23|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116622642|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|24|116622642|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117941206|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|117941206|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119233275|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119233275|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|608145338|Female|Local Extensions from Regional Tumors|2012-2016|~|~|~
20+|0.0|0.0|0.0|Malignant|96|608145338|Female|Local Extensions from Regional Tumors|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120424999|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Malignant|~|120424999|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|~|~|~|Benign/Borderline|~|121659593|Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|26|121659593|Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122838596|Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|19|122838596|Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123988875|Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|16|123988875|Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|594|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|660|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|676|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|640|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|701|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|667|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116622642|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|749|116622642|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|117941206|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.6|Malignant|718|117941206|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|119233275|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|702|119233275|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|608145338|Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|~|~|~
20+|0.5|0.6|0.6|Malignant|3822|608145338|Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|120424999|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|739|120424999|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|121659593|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|814|121659593|Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|122838596|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|754|122838596|Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|123988875|Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|813|123988875|Female|Lymphomas and Hematopoietic Neoplasms|2016|0.6|0.7|0.7
20+|11.9|12.3|12.1|Benign/Borderline|14083|109112165|Female|Meningioma|2004|12.7|13.1|12.9
20+|0.2|0.3|0.2|Malignant|273|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|13.4|13.9|13.7|Benign/Borderline|16154|110320645|Female|Meningioma|2005|14.4|14.9|14.6
20+|0.2|0.3|0.2|Malignant|279|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|14.1|14.5|14.3|Benign/Borderline|17179|111567226|Female|Meningioma|2006|15.2|15.6|15.4
20+|0.2|0.2|0.2|Malignant|251|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.6|15.0|14.8|Benign/Borderline|18066|112783993|Female|Meningioma|2007|15.8|16.3|16.0
20+|0.2|0.2|0.2|Malignant|269|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|15.3|15.7|15.5|Benign/Borderline|19284|114027722|Female|Meningioma|2008|16.7|17.2|16.9
20+|0.2|0.2|0.2|Malignant|216|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|16.3|16.7|16.5|Benign/Borderline|20873|115293599|Female|Meningioma|2009|17.9|18.4|18.1
20+|0.1|0.2|0.2|Malignant|200|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|15.7|16.1|15.9|Benign/Borderline|20446|116622642|Female|Meningioma|2010|17.3|17.8|17.5
20+|0.1|0.2|0.2|Malignant|205|116622642|Female|Meningioma|2010|0.2|0.2|0.2
20+|15.7|16.2|16.0|Benign/Borderline|20806|117941206|Female|Meningioma|2011|17.4|17.9|17.6
20+|0.1|0.2|0.1|Malignant|185|117941206|Female|Meningioma|2011|0.1|0.2|0.2
20+|16.0|16.4|16.2|Benign/Borderline|21488|119233275|Female|Meningioma|2012|17.8|18.3|18.0
20+|0.1|0.2|0.2|Malignant|202|119233275|Female|Meningioma|2012|0.1|0.2|0.2
20+|16.2|16.4|16.3|Benign/Borderline|111794|608145338|Female|Meningioma|2012-2016|18.3|18.5|18.4
20+|0.1|0.2|0.1|Malignant|986|608145338|Female|Meningioma|2012-2016|0.2|0.2|0.2
20+|16.0|16.4|16.2|Benign/Borderline|21796|120424999|Female|Meningioma|2013|17.9|18.3|18.1
20+|0.1|0.2|0.2|Malignant|225|120424999|Female|Meningioma|2013|0.2|0.2|0.2
20+|16.2|16.6|16.4|Benign/Borderline|22504|121659593|Female|Meningioma|2014|18.3|18.7|18.5
20+|0.1|0.2|0.2|Malignant|215|121659593|Female|Meningioma|2014|0.2|0.2|0.2
20+|16.4|16.8|16.6|Benign/Borderline|23184|122838596|Female|Meningioma|2015|18.6|19.1|18.9
20+|0.1|0.2|0.1|Malignant|189|122838596|Female|Meningioma|2015|0.1|0.2|0.2
20+|15.9|16.4|16.2|Benign/Borderline|22822|123988875|Female|Meningioma|2016|18.2|18.6|18.4
20+|0.1|0.1|0.1|Malignant|155|123988875|Female|Meningioma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|197|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|237|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|273|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.2|Malignant|241|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|283|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116622642|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|269|116622642|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|117941206|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|271|117941206|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|119233275|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|240|119233275|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|608145338|Female|Mixed glioma|2012-2016|~|~|~
20+|0.1|0.2|0.1|Malignant|857|608145338|Female|Mixed glioma|2012-2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|120424999|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|248|120424999|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|121659593|Female|Mixed glioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|199|121659593|Female|Mixed glioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122838596|Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|129|122838596|Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123988875|Female|Mixed glioma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|41|123988875|Female|Mixed glioma|2016|0.0|0.0|0.0
20+|0.5|0.6|0.6|Benign/Borderline|687|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|702|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|870|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|720|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|802|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|721|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|834|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|649|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|830|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|751|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|915|115293599|Female|Neoplasm, unspecified|2009|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|785|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|815|116622642|Female|Neoplasm, unspecified|2010|0.7|0.7|0.7
20+|0.4|0.5|0.5|Malignant|647|116622642|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|837|117941206|Female|Neoplasm, unspecified|2011|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|645|117941206|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|863|119233275|Female|Neoplasm, unspecified|2012|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|659|119233275|Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|4034|608145338|Female|Neoplasm, unspecified|2012-2016|0.6|0.7|0.7
20+|0.4|0.5|0.4|Malignant|3327|608145338|Female|Neoplasm, unspecified|2012-2016|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|795|120424999|Female|Neoplasm, unspecified|2013|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|666|120424999|Female|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|860|121659593|Female|Neoplasm, unspecified|2014|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|733|121659593|Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|810|122838596|Female|Neoplasm, unspecified|2015|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|719|122838596|Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|706|123988875|Female|Neoplasm, unspecified|2016|0.5|0.6|0.6
20+|0.3|0.4|0.4|Malignant|550|123988875|Female|Neoplasm, unspecified|2016|0.4|0.5|0.4
20+|2.2|2.4|2.3|Benign/Borderline|2547|109112165|Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2814|110320645|Female|Nerve sheath, benign and malignant|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2934|111567226|Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2933|112783993|Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3059|114027722|Female|Nerve sheath, benign and malignant|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3214|115293599|Female|Nerve sheath, benign and malignant|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|3011|116622642|Female|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|116622642|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3263|117941206|Female|Nerve sheath, benign and malignant|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|20|117941206|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3431|119233275|Female|Nerve sheath, benign and malignant|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|26|119233275|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|17724|608145338|Female|Nerve sheath, benign and malignant|2012-2016|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|112|608145338|Female|Nerve sheath, benign and malignant|2012-2016|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3566|120424999|Female|Nerve sheath, benign and malignant|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|23|120424999|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3655|121659593|Female|Nerve sheath, benign and malignant|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|16|121659593|Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3660|122838596|Female|Nerve sheath, benign and malignant|2015|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|23|122838596|Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3412|123988875|Female|Nerve sheath, benign and malignant|2016|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|24|123988875|Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116622642|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116622642|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117941206|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|23|117941206|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119233275|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|119233275|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|608145338|Female|Neuroepithelial|2012-2016|~|~|~
20+|0.0|0.0|0.0|Malignant|126|608145338|Female|Neuroepithelial|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120424999|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|21|120424999|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121659593|Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121659593|Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122838596|Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|35|122838596|Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|123988875|Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|21|123988875|Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|182|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|187|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|221|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|248|116622642|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|116622642|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|240|117941206|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|117941206|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|210|119233275|Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|119233275|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1075|608145338|Female|Neuronal/glial, neuronal|2012-2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|87|608145338|Female|Neuronal/glial, neuronal|2012-2016|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|183|120424999|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.2
20+|~|~|~|Malignant|~|120424999|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|233|121659593|Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121659593|Female|Neuronal/glial, neuronal|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|122838596|Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122838596|Female|Neuronal/glial, neuronal|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|123988875|Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|27|123988875|Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|355|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|360|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|379|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|370|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|362|114027722|Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|365|115293599|Female|Oligodendroglioma|2009|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116622642|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|331|116622642|Female|Oligodendroglioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117941206|Female|Oligodendroglioma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|318|117941206|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119233275|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|296|119233275|Female|Oligodendroglioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|608145338|Female|Oligodendroglioma|2012-2016|~|~|~
20+|0.3|0.3|0.3|Malignant|1569|608145338|Female|Oligodendroglioma|2012-2016|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120424999|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|342|120424999|Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|121659593|Female|Oligodendroglioma|2014|~|~|~
20+|0.2|0.3|0.3|Malignant|306|121659593|Female|Oligodendroglioma|2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|122838596|Female|Oligodendroglioma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|303|122838596|Female|Oligodendroglioma|2015|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|123988875|Female|Oligodendroglioma|2016|~|~|~
20+|0.2|0.3|0.3|Malignant|322|123988875|Female|Oligodendroglioma|2016|0.2|0.3|0.3
20+|0.0|0.1|0.1|Benign/Borderline|68|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|87|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|52|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|116622642|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|116622642|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|117941206|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|117941206|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|109|119233275|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|119233275|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|471|608145338|Female|Other mesenchymal|2012-2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|185|608145338|Female|Other mesenchymal|2012-2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|104|120424999|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|120424999|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|121659593|Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|33|121659593|Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|89|122838596|Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|122838596|Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|75|123988875|Female|Other mesenchymal|2016|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|123988875|Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|125|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|149|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|163|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116622642|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|166|116622642|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117941206|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|161|117941206|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|119233275|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|122|119233275|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|608145338|Female|Pilocytic astrocytoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|701|608145338|Female|Pilocytic astrocytoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120424999|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|156|120424999|Female|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|121659593|Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|146|121659593|Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122838596|Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|144|122838596|Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|123988875|Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|133|123988875|Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|45|114027722|Female|Pineal parenchymal|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|116622642|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116622642|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|46|117941206|Female|Pineal parenchymal|2011|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|25|117941206|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|119233275|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|119233275|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|218|608145338|Female|Pineal parenchymal|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|134|608145338|Female|Pineal parenchymal|2012-2016|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|54|120424999|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|34|120424999|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|121659593|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|121659593|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|50|122838596|Female|Pineal parenchymal|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|32|122838596|Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|123988875|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|28|123988875|Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|3.7|3.9|3.8|Benign/Borderline|4095|109112165|Female|Pituitary|2004|3.6|3.9|3.8
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.2|4.5|4.3|Benign/Borderline|4765|110320645|Female|Pituitary|2005|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.6|4.9|4.7|Benign/Borderline|5250|111567226|Female|Pituitary|2006|4.6|4.8|4.7
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.7|5.0|4.9|Benign/Borderline|5441|112783993|Female|Pituitary|2007|4.7|5.0|4.8
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|5853|114027722|Female|Pituitary|2008|5.0|5.3|5.1
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.5|5.8|5.7|Benign/Borderline|6473|115293599|Female|Pituitary|2009|5.5|5.8|5.6
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Pituitary|2009|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|6434|116622642|Female|Pituitary|2010|5.4|5.7|5.5
20+|0.0|0.0|0.0|Malignant|16|116622642|Female|Pituitary|2010|0.0|0.0|0.0
20+|5.6|5.9|5.7|Benign/Borderline|6599|117941206|Female|Pituitary|2011|5.5|5.7|5.6
20+|~|~|~|Malignant|~|117941206|Female|Pituitary|2011|~|~|~
20+|5.9|6.2|6.0|Benign/Borderline|7002|119233275|Female|Pituitary|2012|5.7|6.0|5.9
20+|~|~|~|Malignant|~|119233275|Female|Pituitary|2012|~|~|~
20+|5.8|5.9|5.8|Benign/Borderline|34881|608145338|Female|Pituitary|2012-2016|5.7|5.8|5.7
20+|0.0|0.0|0.0|Malignant|66|608145338|Female|Pituitary|2012-2016|0.0|0.0|0.0
20+|5.7|6.0|5.8|Benign/Borderline|6901|120424999|Female|Pituitary|2013|5.6|5.9|5.7
20+|~|~|~|Malignant|~|120424999|Female|Pituitary|2013|~|~|~
20+|5.7|6.0|5.9|Benign/Borderline|6977|121659593|Female|Pituitary|2014|5.6|5.9|5.7
20+|~|~|~|Malignant|~|121659593|Female|Pituitary|2014|~|~|~
20+|5.8|6.1|6.0|Benign/Borderline|7165|122838596|Female|Pituitary|2015|5.7|6.0|5.8
20+|~|~|~|Malignant|~|122838596|Female|Pituitary|2015|~|~|~
20+|5.5|5.7|5.6|Benign/Borderline|6836|123988875|Female|Pituitary|2016|5.4|5.6|5.5
20+|~|~|~|Malignant|~|123988875|Female|Pituitary|2016|~|~|~
20+|19.5|20.0|19.8|Benign/Borderline|22528|109112165|Female|Total|2004|20.4|20.9|20.6
20+|7.5|7.8|7.6|Malignant|8740|109112165|Female|Total|2004|7.8|8.2|8.0
20+|22.1|22.6|22.4|Benign/Borderline|25867|110320645|Female|Total|2005|23.2|23.7|23.4
20+|7.5|7.8|7.7|Malignant|8916|110320645|Female|Total|2005|7.9|8.3|8.1
20+|23.2|23.7|23.4|Benign/Borderline|27517|111567226|Female|Total|2006|24.4|25.0|24.7
20+|7.5|7.8|7.6|Malignant|8979|111567226|Female|Total|2006|7.9|8.2|8.0
20+|23.8|24.4|24.1|Benign/Borderline|28682|112783993|Female|Total|2007|25.1|25.7|25.4
20+|7.4|7.7|7.6|Malignant|9065|112783993|Female|Total|2007|7.9|8.2|8.0
20+|25.0|25.6|25.3|Benign/Borderline|30586|114027722|Female|Total|2008|26.5|27.1|26.8
20+|7.4|7.7|7.6|Malignant|9225|114027722|Female|Total|2008|7.9|8.3|8.1
20+|26.7|27.3|27.0|Benign/Borderline|33108|115293599|Female|Total|2009|28.4|29.0|28.7
20+|7.4|7.7|7.5|Malignant|9367|115293599|Female|Total|2009|8.0|8.3|8.1
20+|25.8|26.4|26.1|Benign/Borderline|32502|116622642|Female|Total|2010|27.6|28.2|27.9
20+|7.2|7.5|7.4|Malignant|9300|116622642|Female|Total|2010|7.8|8.1|8.0
20+|26.2|26.8|26.5|Benign/Borderline|33372|117941206|Female|Total|2011|28.0|28.6|28.3
20+|7.0|7.3|7.2|Malignant|9188|117941206|Female|Total|2011|7.6|8.0|7.8
20+|26.8|27.4|27.1|Benign/Borderline|34647|119233275|Female|Total|2012|28.8|29.4|29.1
20+|7.1|7.4|7.3|Malignant|9458|119233275|Female|Total|2012|7.8|8.1|7.9
20+|26.8|27.0|26.9|Benign/Borderline|177283|608145338|Female|Total|2012-2016|29.0|29.3|29.2
20+|7.0|7.2|7.1|Malignant|47836|608145338|Female|Total|2012-2016|7.8|7.9|7.9
20+|26.6|27.2|26.9|Benign/Borderline|34906|120424999|Female|Total|2013|28.7|29.3|29.0
20+|7.1|7.4|7.2|Malignant|9619|120424999|Female|Total|2013|7.8|8.1|8.0
20+|26.9|27.5|27.2|Benign/Borderline|35790|121659593|Female|Total|2014|29.1|29.7|29.4
20+|6.9|7.1|7.0|Malignant|9469|121659593|Female|Total|2014|7.6|7.9|7.8
20+|27.0|27.6|27.3|Benign/Borderline|36558|122838596|Female|Total|2015|29.5|30.1|29.8
20+|7.0|7.3|7.2|Malignant|9806|122838596|Female|Total|2015|7.8|8.1|8.0
20+|25.8|26.4|26.1|Benign/Borderline|35382|123988875|Female|Total|2016|28.2|28.8|28.5
20+|6.7|6.9|6.8|Malignant|9484|123988875|Female|Total|2016|7.5|7.8|7.6
20+|2.2|2.4|2.3|Benign/Borderline|2547|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2817|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2935|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2934|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3061|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3217|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.5|2.4|Benign/Borderline|3014|116622642|Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|116622642|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3265|117941206|Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|20|117941206|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3431|119233275|Female|Tumors of Cranial and Spinal Nerves|2012|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|26|119233275|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|17738|608145338|Female|Tumors of Cranial and Spinal Nerves|2012-2016|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|112|608145338|Female|Tumors of Cranial and Spinal Nerves|2012-2016|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3567|120424999|Female|Tumors of Cranial and Spinal Nerves|2013|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|23|120424999|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3661|121659593|Female|Tumors of Cranial and Spinal Nerves|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|16|121659593|Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3663|122838596|Female|Tumors of Cranial and Spinal Nerves|2015|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|23|122838596|Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3416|123988875|Female|Tumors of Cranial and Spinal Nerves|2016|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|24|123988875|Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|0.3|0.4|0.4|Benign/Borderline|382|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.4
20+|6.1|6.4|6.2|Malignant|7057|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|441|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7145|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|482|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7224|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|480|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7386|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|488|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7420|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|510|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.1|6.3|6.2|Malignant|7616|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.5|6.8|6.6
20+|0.4|0.5|0.5|Benign/Borderline|547|116622642|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.1|Malignant|7586|116622642|Female|Tumors of Neuroepthelial Tissue|2010|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|559|117941206|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.1|5.9|Malignant|7541|117941206|Female|Tumors of Neuroepthelial Tissue|2011|6.3|6.5|6.4
20+|0.4|0.5|0.5|Benign/Borderline|535|119233275|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.4
20+|5.9|6.2|6.0|Malignant|7781|119233275|Female|Tumors of Neuroepthelial Tissue|2012|6.4|6.7|6.5
20+|0.5|0.5|0.5|Benign/Borderline|2793|608145338|Female|Tumors of Neuroepthelial Tissue|2012-2016|0.4|0.5|0.5
20+|5.8|5.9|5.9|Malignant|39158|608145338|Female|Tumors of Neuroepthelial Tissue|2012-2016|6.4|6.5|6.4
20+|0.4|0.5|0.4|Benign/Borderline|525|120424999|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.4
20+|5.9|6.1|6.0|Malignant|7882|120424999|Female|Tumors of Neuroepthelial Tissue|2013|6.4|6.7|6.5
20+|0.5|0.5|0.5|Benign/Borderline|590|121659593|Female|Tumors of Neuroepthelial Tissue|2014|0.4|0.5|0.5
20+|5.5|5.8|5.7|Malignant|7599|121659593|Female|Tumors of Neuroepthelial Tissue|2014|6.1|6.4|6.2
20+|0.5|0.5|0.5|Benign/Borderline|596|122838596|Female|Tumors of Neuroepthelial Tissue|2015|0.4|0.5|0.5
20+|5.8|6.1|5.9|Malignant|8033|122838596|Female|Tumors of Neuroepthelial Tissue|2015|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|547|123988875|Female|Tumors of Neuroepthelial Tissue|2016|0.4|0.5|0.4
20+|5.5|5.8|5.7|Malignant|7863|123988875|Female|Tumors of Neuroepthelial Tissue|2016|6.2|6.5|6.3
20+|3.8|4.1|4.0|Benign/Borderline|4299|109112165|Female|Tumors of Sellar Region|2004|3.8|4.1|3.9
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|4949|110320645|Female|Tumors of Sellar Region|2005|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.8|5.1|4.9|Benign/Borderline|5452|111567226|Female|Tumors of Sellar Region|2006|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.9|5.2|5.1|Benign/Borderline|5661|112783993|Female|Tumors of Sellar Region|2007|4.9|5.2|5.0
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|5.3|5.5|5.4|Benign/Borderline|6077|114027722|Female|Tumors of Sellar Region|2008|5.2|5.5|5.3
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.7|6.0|5.9|Benign/Borderline|6703|115293599|Female|Tumors of Sellar Region|2009|5.7|6.0|5.8
20+|0.0|0.0|0.0|Malignant|18|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.7|5.9|5.8|Benign/Borderline|6672|116622642|Female|Tumors of Sellar Region|2010|5.6|5.9|5.7
20+|0.0|0.0|0.0|Malignant|16|116622642|Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.7|6.0|5.9|Benign/Borderline|6817|117941206|Female|Tumors of Sellar Region|2011|5.6|5.9|5.8
20+|~|~|~|Malignant|~|117941206|Female|Tumors of Sellar Region|2011|~|~|~
20+|6.0|6.3|6.2|Benign/Borderline|7225|119233275|Female|Tumors of Sellar Region|2012|5.9|6.2|6.1
20+|~|~|~|Malignant|~|119233275|Female|Tumors of Sellar Region|2012|~|~|~
20+|6.0|6.1|6.0|Benign/Borderline|36004|608145338|Female|Tumors of Sellar Region|2012-2016|5.9|6.0|5.9
20+|0.0|0.0|0.0|Malignant|69|608145338|Female|Tumors of Sellar Region|2012-2016|0.0|0.0|0.0
20+|5.9|6.1|6.0|Benign/Borderline|7144|120424999|Female|Tumors of Sellar Region|2013|5.8|6.1|5.9
20+|0.0|0.0|0.0|Malignant|16|120424999|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.9|6.2|6.0|Benign/Borderline|7200|121659593|Female|Tumors of Sellar Region|2014|5.8|6.1|5.9
20+|~|~|~|Malignant|~|121659593|Female|Tumors of Sellar Region|2014|~|~|~
20+|6.0|6.3|6.1|Benign/Borderline|7398|122838596|Female|Tumors of Sellar Region|2015|5.9|6.2|6.0
20+|0.0|0.0|0.0|Malignant|16|122838596|Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.6|5.9|5.8|Benign/Borderline|7037|123988875|Female|Tumors of Sellar Region|2016|5.5|5.8|5.7
20+|~|~|~|Malignant|~|123988875|Female|Tumors of Sellar Region|2016|~|~|~
20+|12.2|12.6|12.4|Benign/Borderline|14357|109112165|Female|Tumors of the Meninges|2004|12.9|13.4|13.2
20+|0.2|0.3|0.3|Malignant|299|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.7|14.2|13.9|Benign/Borderline|16465|110320645|Female|Tumors of the Meninges|2005|14.7|15.2|14.9
20+|0.2|0.3|0.3|Malignant|306|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.3|14.8|14.6|Benign/Borderline|17488|111567226|Female|Tumors of the Meninges|2006|15.4|15.9|15.7
20+|0.2|0.3|0.2|Malignant|282|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.8|15.3|15.1|Benign/Borderline|18366|112783993|Female|Tumors of the Meninges|2007|16.0|16.5|16.3
20+|0.2|0.3|0.3|Malignant|309|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.6|16.0|15.8|Benign/Borderline|19625|114027722|Female|Tumors of the Meninges|2008|17.0|17.5|17.2
20+|0.2|0.2|0.2|Malignant|269|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|16.6|17.0|16.8|Benign/Borderline|21202|115293599|Female|Tumors of the Meninges|2009|18.1|18.6|18.4
20+|0.2|0.2|0.2|Malignant|227|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|15.9|16.4|16.2|Benign/Borderline|20766|116622642|Female|Tumors of the Meninges|2010|17.6|18.1|17.8
20+|0.2|0.2|0.2|Malignant|240|116622642|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|16.0|16.5|16.2|Benign/Borderline|21143|117941206|Female|Tumors of the Meninges|2011|17.7|18.2|17.9
20+|0.1|0.2|0.2|Malignant|216|117941206|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|16.3|16.7|16.5|Benign/Borderline|21852|119233275|Female|Tumors of the Meninges|2012|18.1|18.6|18.3
20+|0.2|0.2|0.2|Malignant|240|119233275|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|16.5|16.7|16.6|Benign/Borderline|113456|608145338|Female|Tumors of the Meninges|2012-2016|18.5|18.8|18.7
20+|0.2|0.2|0.2|Malignant|1187|608145338|Female|Tumors of the Meninges|2012-2016|0.2|0.2|0.2
20+|16.3|16.7|16.5|Benign/Borderline|22130|120424999|Female|Tumors of the Meninges|2013|18.1|18.6|18.4
20+|0.2|0.2|0.2|Malignant|268|120424999|Female|Tumors of the Meninges|2013|0.2|0.3|0.2
20+|16.4|16.9|16.6|Benign/Borderline|22813|121659593|Female|Tumors of the Meninges|2014|18.5|19.0|18.8
20+|0.2|0.2|0.2|Malignant|253|121659593|Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|16.6|17.1|16.8|Benign/Borderline|23513|122838596|Female|Tumors of the Meninges|2015|18.9|19.4|19.1
20+|0.1|0.2|0.2|Malignant|230|122838596|Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|16.2|16.6|16.4|Benign/Borderline|23148|123988875|Female|Tumors of the Meninges|2016|18.4|18.9|18.7
20+|0.1|0.2|0.1|Malignant|196|123988875|Female|Tumors of the Meninges|2016|0.1|0.2|0.2
20+|0.7|0.9|0.8|Benign/Borderline|925|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|708|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1157|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|724|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|1.0|Benign/Borderline|1124|111567226|Female|Unclassified Tumors|2006|0.9|1.1|1.0
20+|0.5|0.6|0.6|Malignant|726|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.7
20+|0.9|1.1|1.0|Benign/Borderline|1204|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|652|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1301|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|765|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.2|1.2|Benign/Borderline|1432|115293599|Female|Unclassified Tumors|2009|1.2|1.3|1.2
20+|0.5|0.6|0.6|Malignant|792|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1470|116622642|Female|Unclassified Tumors|2010|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|654|116622642|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.2|1.3|1.3|Benign/Borderline|1551|117941206|Female|Unclassified Tumors|2011|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|650|117941206|Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.2|1.3|1.2|Benign/Borderline|1568|119233275|Female|Unclassified Tumors|2012|1.3|1.4|1.3
20+|0.4|0.5|0.5|Malignant|664|119233275|Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.1|1.1|Benign/Borderline|7136|608145338|Female|Unclassified Tumors|2012-2016|1.1|1.2|1.2
20+|0.4|0.5|0.5|Malignant|3357|608145338|Female|Unclassified Tumors|2012-2016|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|1515|120424999|Female|Unclassified Tumors|2013|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|670|120424999|Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|1494|121659593|Female|Unclassified Tumors|2014|1.2|1.3|1.2
20+|0.5|0.5|0.5|Malignant|740|121659593|Female|Unclassified Tumors|2014|0.6|0.7|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1355|122838596|Female|Unclassified Tumors|2015|1.0|1.2|1.1
20+|0.4|0.5|0.5|Malignant|727|122838596|Female|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.8|1.0|0.9|Benign/Borderline|1204|123988875|Female|Unclassified Tumors|2016|0.9|1.0|1.0
20+|0.3|0.4|0.4|Malignant|556|123988875|Female|Unclassified Tumors|2016|0.4|0.5|0.4
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|49|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|62|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|57|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|115293599|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|70|116622642|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|116622642|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|80|117941206|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|117941206|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|98|119233275|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|119233275|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|489|608145338|Female|Unique astrocytoma variants|2012-2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|157|608145338|Female|Unique astrocytoma variants|2012-2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|120424999|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|120424999|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|97|121659593|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|121659593|Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|101|122838596|Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|122838596|Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|98|123988875|Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|123988875|Female|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109533809|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109533809|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110873057|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|110873057|Male|All other|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112272700|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|21|112272700|Male|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|106|574070384|Male|All other|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|127|574070384|Male|All other|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|113556645|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|113556645|Male|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114846861|Male|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114846861|Male|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|116104785|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|116104785|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|39|117289393|Male|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|25|117289393|Male|All other|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|670|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|699|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|698|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|673|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|708|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|713|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109533809|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|705|109533809|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|110873057|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|707|110873057|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112272700|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|750|112272700|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|574070384|Male|Anaplastic astrocytoma|2012-2016|~|~|~
20+|0.6|0.7|0.7|Malignant|3900|574070384|Male|Anaplastic astrocytoma|2012-2016|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113556645|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|787|113556645|Male|Anaplastic astrocytoma|2013|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|114846861|Male|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|789|114846861|Male|Anaplastic astrocytoma|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|116104785|Male|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|774|116104785|Male|Anaplastic astrocytoma|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|117289393|Male|Anaplastic astrocytoma|2016|~|~|~
20+|0.6|0.7|0.7|Malignant|800|117289393|Male|Anaplastic astrocytoma|2016|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|210|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|208|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|216|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|183|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|188|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|189|108197539|Male|Anaplastic oligodendroglioma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109533809|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.2|0.2|0.2|Malignant|191|109533809|Male|Anaplastic oligodendroglioma|2010|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110873057|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|182|110873057|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112272700|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|187|112272700|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|574070384|Male|Anaplastic oligodendroglioma|2012-2016|~|~|~
20+|0.2|0.2|0.2|Malignant|992|574070384|Male|Anaplastic oligodendroglioma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113556645|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|221|113556645|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114846861|Male|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|203|114846861|Male|Anaplastic oligodendroglioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|116104785|Male|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.2|Malignant|189|116104785|Male|Anaplastic oligodendroglioma|2015|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|117289393|Male|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.2|Malignant|192|117289393|Male|Anaplastic oligodendroglioma|2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|637|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|635|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|648|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|626|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|624|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|572|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109533809|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|612|109533809|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|110873057|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|581|110873057|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|112272700|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.5|0.5|0.5|Malignant|554|112272700|Male|Astrocytoma, NOS|2012|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|574070384|Male|Astrocytoma, NOS|2012-2016|~|~|~
20+|0.5|0.5|0.5|Malignant|3042|574070384|Male|Astrocytoma, NOS|2012-2016|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113556645|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.5|0.5|0.5|Malignant|564|113556645|Male|Astrocytoma, NOS|2013|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114846861|Male|Astrocytoma, NOS|2014|~|~|~
20+|0.5|0.6|0.5|Malignant|590|114846861|Male|Astrocytoma, NOS|2014|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|116104785|Male|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|670|116104785|Male|Astrocytoma, NOS|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|117289393|Male|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|664|117289393|Male|Astrocytoma, NOS|2016|0.5|0.6|0.6
20+|0.0|0.0|0.0|Benign/Borderline|24|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|109533809|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109533809|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|110873057|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110873057|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|112272700|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112272700|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|171|574070384|Male|Choroid plexus|2012-2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|574070384|Male|Choroid plexus|2012-2016|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|113556645|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113556645|Male|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|42|114846861|Male|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114846861|Male|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|116104785|Male|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116104785|Male|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|117289393|Male|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117289393|Male|Choroid plexus|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|185|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|231|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|191|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|199|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|109533809|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109533809|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|194|110873057|Male|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110873057|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|216|112272700|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112272700|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1089|574070384|Male|Craniopharyngioma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|574070384|Male|Craniopharyngioma|2012-2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|113556645|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113556645|Male|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|202|114846861|Male|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114846861|Male|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|116104785|Male|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116104785|Male|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|117289393|Male|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117289393|Male|Craniopharyngioma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|144|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|184|105697783|Male|Diffuse astrocytoma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|209|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|208|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109533809|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|187|109533809|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110873057|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|136|110873057|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112272700|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|113|112272700|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|574070384|Male|Diffuse astrocytoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|354|574070384|Male|Diffuse astrocytoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113556645|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|102|113556645|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114846861|Male|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|69|114846861|Male|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116104785|Male|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.1|0.0|Malignant|48|116104785|Male|Diffuse astrocytoma|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|117289393|Male|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|22|117289393|Male|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|98|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|123|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|133|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109533809|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|125|109533809|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110873057|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|110873057|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112272700|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112272700|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|574070384|Male|Embryonal/primitive/medulloblastoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|514|574070384|Male|Embryonal/primitive/medulloblastoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113556645|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|97|113556645|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114846861|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|108|114846861|Male|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116104785|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|99|116104785|Male|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117289393|Male|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|118|117289393|Male|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|150|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|159|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|147|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|109533809|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109533809|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|151|110873057|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|110873057|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|161|112272700|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112272700|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|805|574070384|Male|Ependymoma variants|2012-2016|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|19|574070384|Male|Ependymoma variants|2012-2016|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|157|113556645|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|113556645|Male|Ependymoma variants|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|166|114846861|Male|Ependymoma variants|2014|0.1|0.2|0.1
20+|~|~|~|Malignant|~|114846861|Male|Ependymoma variants|2014|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|160|116104785|Male|Ependymoma variants|2015|0.1|0.2|0.1
20+|~|~|~|Malignant|~|116104785|Male|Ependymoma variants|2015|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|161|117289393|Male|Ependymoma variants|2016|0.1|0.2|0.1
20+|~|~|~|Malignant|~|117289393|Male|Ependymoma variants|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|302|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|300|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|291|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|289|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|321|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|336|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109533809|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|331|109533809|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110873057|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|296|110873057|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112272700|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|325|112272700|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|62|574070384|Male|Ependymoma/anaplastic ependymoma|2012-2016|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1561|574070384|Male|Ependymoma/anaplastic ependymoma|2012-2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113556645|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|301|113556645|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|22|114846861|Male|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|320|114846861|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116104785|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|305|116104785|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117289393|Male|Ependymoma/anaplastic ependymoma|2016|~|~|~
20+|0.2|0.3|0.3|Malignant|310|117289393|Male|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|54|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|77|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|33|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|109533809|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109533809|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|110873057|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|60|110873057|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|112272700|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|112272700|Male|Germ Cell Tumors|2012|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|136|574070384|Male|Germ Cell Tumors|2012-2016|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|268|574070384|Male|Germ Cell Tumors|2012-2016|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|113556645|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|113556645|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|114846861|Male|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|61|114846861|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|27|116104785|Male|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|55|116104785|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|117289393|Male|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|65|117289393|Male|Germ Cell Tumors|2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5468|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.5|5.8|5.6|Malignant|5544|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5512|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5818|105697783|Male|Glioblastoma|2007|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.7|Malignant|6002|106947980|Male|Glioblastoma|2008|5.5|5.8|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.6|Malignant|6010|108197539|Male|Glioblastoma|2009|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|109533809|Male|Glioblastoma|2010|~|~|~
20+|5.4|5.6|5.5|Malignant|6121|109533809|Male|Glioblastoma|2010|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|110873057|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.7|5.5|Malignant|6298|110873057|Male|Glioblastoma|2011|5.5|5.8|5.7
20+|~|~|~|Benign/Borderline|~|112272700|Male|Glioblastoma|2012|~|~|~
20+|5.5|5.7|5.6|Malignant|6527|112272700|Male|Glioblastoma|2012|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|574070384|Male|Glioblastoma|2012-2016|~|~|~
20+|5.5|5.6|5.5|Malignant|33825|574070384|Male|Glioblastoma|2012-2016|5.8|6.0|5.9
20+|~|~|~|Benign/Borderline|~|113556645|Male|Glioblastoma|2013|~|~|~
20+|5.4|5.7|5.6|Malignant|6630|113556645|Male|Glioblastoma|2013|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|114846861|Male|Glioblastoma|2014|~|~|~
20+|5.4|5.7|5.6|Malignant|6790|114846861|Male|Glioblastoma|2014|5.8|6.1|5.9
20+|~|~|~|Benign/Borderline|~|116104785|Male|Glioblastoma|2015|~|~|~
20+|5.4|5.7|5.5|Malignant|6870|116104785|Male|Glioblastoma|2015|5.8|6.1|5.9
20+|~|~|~|Benign/Borderline|~|117289393|Male|Glioblastoma|2016|~|~|~
20+|5.4|5.6|5.5|Malignant|7008|117289393|Male|Glioblastoma|2016|5.8|6.1|6.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|422|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|441|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|445|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|463|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|106947980|Male|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|479|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|456|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109533809|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|410|109533809|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|110873057|Male|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|487|110873057|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|112272700|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|486|112272700|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|85|574070384|Male|Glioma malignant, NOS|2012-2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2405|574070384|Male|Glioma malignant, NOS|2012-2016|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|113556645|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.4|0.4|0.4|Malignant|453|113556645|Male|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114846861|Male|Glioma malignant, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|492|114846861|Male|Glioma malignant, NOS|2014|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|116104785|Male|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|472|116104785|Male|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|26|117289393|Male|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|502|117289393|Male|Glioma malignant, NOS|2016|0.4|0.5|0.4
20+|0.2|0.3|0.2|Benign/Borderline|249|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|286|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|276|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|256|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|288|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|273|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.3
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|303|109533809|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109533809|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|275|110873057|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110873057|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|282|112272700|Male|Hemangioblastoma|2012|0.2|0.3|0.3
20+|~|~|~|Malignant|~|112272700|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1373|574070384|Male|Hemangioblastoma|2012-2016|0.2|0.3|0.2
20+|~|~|~|Malignant|~|574070384|Male|Hemangioblastoma|2012-2016|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|274|113556645|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|113556645|Male|Hemangioblastoma|2013|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|268|114846861|Male|Hemangioblastoma|2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|114846861|Male|Hemangioblastoma|2014|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|284|116104785|Male|Hemangioblastoma|2015|0.2|0.3|0.2
20+|~|~|~|Malignant|~|116104785|Male|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|265|117289393|Male|Hemangioblastoma|2016|0.2|0.3|0.2
20+|~|~|~|Malignant|~|117289393|Male|Hemangioblastoma|2016|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|138|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|197|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|231|104488268|Male|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|264|105697783|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|323|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|421|108197539|Male|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|443|109533809|Male|Hemangioma|2010|0.4|0.4|0.4
20+|~|~|~|Malignant|~|109533809|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|499|110873057|Male|Hemangioma|2011|0.4|0.5|0.5
20+|~|~|~|Malignant|~|110873057|Male|Hemangioma|2011|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|502|112272700|Male|Hemangioma|2012|0.4|0.5|0.4
20+|~|~|~|Malignant|~|112272700|Male|Hemangioma|2012|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2308|574070384|Male|Hemangioma|2012-2016|0.4|0.4|0.4
20+|~|~|~|Malignant|~|574070384|Male|Hemangioma|2012-2016|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|501|113556645|Male|Hemangioma|2013|0.4|0.5|0.4
20+|~|~|~|Malignant|~|113556645|Male|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|488|114846861|Male|Hemangioma|2014|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114846861|Male|Hemangioma|2014|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|430|116104785|Male|Hemangioma|2015|0.3|0.4|0.4
20+|~|~|~|Malignant|~|116104785|Male|Hemangioma|2015|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|387|117289393|Male|Hemangioma|2016|0.3|0.4|0.3
20+|~|~|~|Malignant|~|117289393|Male|Hemangioma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|26|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|35|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|29|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109533809|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|29|109533809|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110873057|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|22|110873057|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112272700|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112272700|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|574070384|Male|Local Extensions from Regional Tumors|2012-2016|~|~|~
20+|0.0|0.0|0.0|Malignant|130|574070384|Male|Local Extensions from Regional Tumors|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113556645|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|28|113556645|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114846861|Male|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|114846861|Male|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116104785|Male|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|23|116104785|Male|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117289393|Male|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|26|117289393|Male|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|750|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|780|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|760|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|736|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|774|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|762|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109533809|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.8|0.7|Malignant|759|109533809|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|110873057|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|810|110873057|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|112272700|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|755|112272700|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|574070384|Male|Lymphomas and Hematopoietic Neoplasms|2012-2016|~|~|~
20+|0.6|0.7|0.7|Malignant|3908|574070384|Male|Lymphomas and Hematopoietic Neoplasms|2012-2016|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113556645|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|729|113556645|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|114846861|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|817|114846861|Male|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|116104785|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|819|116104785|Male|Lymphomas and Hematopoietic Neoplasms|2015|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|117289393|Male|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.7|0.6|Malignant|788|117289393|Male|Lymphomas and Hematopoietic Neoplasms|2016|0.6|0.7|0.7
20+|5.0|5.3|5.2|Benign/Borderline|4876|101938779|Male|Meningioma|2004|4.6|4.9|4.8
20+|0.2|0.2|0.2|Malignant|169|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.6|5.9|5.7|Benign/Borderline|5450|103190694|Male|Meningioma|2005|5.1|5.4|5.3
20+|0.1|0.2|0.2|Malignant|155|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.9|6.2|6.0|Benign/Borderline|5861|104488268|Male|Meningioma|2006|5.5|5.8|5.6
20+|0.1|0.2|0.2|Malignant|153|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|6.0|6.3|6.1|Benign/Borderline|6062|105697783|Male|Meningioma|2007|5.6|5.9|5.7
20+|0.1|0.2|0.2|Malignant|177|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.4|6.7|6.5|Benign/Borderline|6638|106947980|Male|Meningioma|2008|6.1|6.4|6.2
20+|0.1|0.2|0.1|Malignant|147|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.8|7.2|7.0|Benign/Borderline|7193|108197539|Male|Meningioma|2009|6.5|6.8|6.6
20+|0.1|0.2|0.1|Malignant|151|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.7|7.0|6.9|Benign/Borderline|7220|109533809|Male|Meningioma|2010|6.4|6.7|6.6
20+|0.1|0.1|0.1|Malignant|120|109533809|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.7|7.0|6.9|Benign/Borderline|7393|110873057|Male|Meningioma|2011|6.5|6.8|6.7
20+|0.1|0.2|0.1|Malignant|142|110873057|Male|Meningioma|2011|0.1|0.2|0.1
20+|6.7|7.0|6.8|Benign/Borderline|7516|112272700|Male|Meningioma|2012|6.5|6.8|6.7
20+|0.1|0.2|0.1|Malignant|151|112272700|Male|Meningioma|2012|0.1|0.2|0.1
20+|6.9|7.1|7.0|Benign/Borderline|40378|574070384|Male|Meningioma|2012-2016|7.0|7.1|7.0
20+|0.1|0.1|0.1|Malignant|764|574070384|Male|Meningioma|2012-2016|0.1|0.1|0.1
20+|7.0|7.3|7.1|Benign/Borderline|8018|113556645|Male|Meningioma|2013|6.9|7.2|7.1
20+|0.1|0.2|0.1|Malignant|155|113556645|Male|Meningioma|2013|0.1|0.2|0.1
20+|6.9|7.2|7.0|Benign/Borderline|8081|114846861|Male|Meningioma|2014|6.9|7.2|7.0
20+|0.1|0.2|0.1|Malignant|166|114846861|Male|Meningioma|2014|0.1|0.2|0.1
20+|7.0|7.3|7.2|Benign/Borderline|8453|116104785|Male|Meningioma|2015|7.1|7.4|7.3
20+|0.1|0.1|0.1|Malignant|144|116104785|Male|Meningioma|2015|0.1|0.1|0.1
20+|6.8|7.1|6.9|Benign/Borderline|8310|117289393|Male|Meningioma|2016|6.9|7.2|7.1
20+|0.1|0.1|0.1|Malignant|148|117289393|Male|Meningioma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|295|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|364|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|345|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|338|106947980|Male|Mixed glioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|394|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109533809|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|344|109533809|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110873057|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|363|110873057|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112272700|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|330|112272700|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|574070384|Male|Mixed glioma|2012-2016|~|~|~
20+|0.2|0.2|0.2|Malignant|1170|574070384|Male|Mixed glioma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113556645|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|370|113556645|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114846861|Male|Mixed glioma|2014|~|~|~
20+|0.2|0.3|0.2|Malignant|265|114846861|Male|Mixed glioma|2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116104785|Male|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|144|116104785|Male|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117289393|Male|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.1|Malignant|61|117289393|Male|Mixed glioma|2016|0.0|0.1|0.1
20+|0.5|0.6|0.6|Benign/Borderline|506|101938779|Male|Neoplasm, unspecified|2004|0.5|0.5|0.5
20+|0.6|0.7|0.7|Malignant|610|101938779|Male|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|627|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|602|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|613|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|564|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|591|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|567|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|601|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|618|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|609|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|639|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|658|109533809|Male|Neoplasm, unspecified|2010|0.6|0.6|0.6
20+|0.5|0.6|0.6|Malignant|596|109533809|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|627|110873057|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|606|110873057|Male|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|701|112272700|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|620|112272700|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|3155|574070384|Male|Neoplasm, unspecified|2012-2016|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|3094|574070384|Male|Neoplasm, unspecified|2012-2016|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|676|113556645|Male|Neoplasm, unspecified|2013|0.6|0.6|0.6
20+|0.5|0.6|0.6|Malignant|611|113556645|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|627|114846861|Male|Neoplasm, unspecified|2014|0.5|0.6|0.5
20+|0.6|0.7|0.6|Malignant|666|114846861|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|616|116104785|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.6|0.5|Malignant|619|116104785|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.4|0.5|0.5|Benign/Borderline|535|117289393|Male|Neoplasm, unspecified|2016|0.4|0.5|0.5
20+|0.5|0.5|0.5|Malignant|578|117289393|Male|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2320|101938779|Male|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2670|103190694|Male|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2641|104488268|Male|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2724|105697783|Male|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2689|106947980|Male|Nerve sheath, benign and malignant|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2867|108197539|Male|Nerve sheath, benign and malignant|2009|2.6|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2874|109533809|Male|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|23|109533809|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2972|110873057|Male|Nerve sheath, benign and malignant|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|16|110873057|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3149|112272700|Male|Nerve sheath, benign and malignant|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|24|112272700|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.7|2.7|Benign/Borderline|16209|574070384|Male|Nerve sheath, benign and malignant|2012-2016|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|105|574070384|Male|Nerve sheath, benign and malignant|2012-2016|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3190|113556645|Male|Nerve sheath, benign and malignant|2013|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|113556645|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3428|114846861|Male|Nerve sheath, benign and malignant|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|22|114846861|Male|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3348|116104785|Male|Nerve sheath, benign and malignant|2015|2.8|3.0|2.9
20+|~|~|~|Malignant|~|116104785|Male|Nerve sheath, benign and malignant|2015|~|~|~
20+|2.4|2.6|2.5|Benign/Borderline|3094|117289393|Male|Nerve sheath, benign and malignant|2016|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|23|117289393|Male|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109533809|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109533809|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110873057|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|29|110873057|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112272700|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112272700|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|574070384|Male|Neuroepithelial|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|147|574070384|Male|Neuroepithelial|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113556645|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|27|113556645|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114846861|Male|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|36|114846861|Male|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116104785|Male|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|31|116104785|Male|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117289393|Male|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|25|117289393|Male|Neuroepithelial|2016|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|161|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|190|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|36|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|200|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|183|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|218|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|216|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|233|109533809|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109533809|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|186|110873057|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|110873057|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|205|112272700|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112272700|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1130|574070384|Male|Neuronal/glial, neuronal|2012-2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|95|574070384|Male|Neuronal/glial, neuronal|2012-2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|214|113556645|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|113556645|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|219|114846861|Male|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|114846861|Male|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|259|116104785|Male|Neuronal/glial, neuronal|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Malignant|16|116104785|Male|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|233|117289393|Male|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|117289393|Male|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|476|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|440|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|465|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|438|105697783|Male|Oligodendroglioma|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|403|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|471|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109533809|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|466|109533809|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|110873057|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|441|110873057|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112272700|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|364|112272700|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|574070384|Male|Oligodendroglioma|2012-2016|~|~|~
20+|0.3|0.4|0.3|Malignant|1915|574070384|Male|Oligodendroglioma|2012-2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113556645|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|365|113556645|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114846861|Male|Oligodendroglioma|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|408|114846861|Male|Oligodendroglioma|2014|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|116104785|Male|Oligodendroglioma|2015|~|~|~
20+|0.3|0.4|0.3|Malignant|393|116104785|Male|Oligodendroglioma|2015|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|117289393|Male|Oligodendroglioma|2016|~|~|~
20+|0.3|0.4|0.3|Malignant|385|117289393|Male|Oligodendroglioma|2016|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|82|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|73|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|36|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|38|105697783|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|48|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|78|109533809|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|109533809|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|66|110873057|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|110873057|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|112272700|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|112272700|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|430|574070384|Male|Other mesenchymal|2012-2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|209|574070384|Male|Other mesenchymal|2012-2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|74|113556645|Male|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|113556645|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|114846861|Male|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|48|114846861|Male|Other mesenchymal|2014|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|106|116104785|Male|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|116104785|Male|Other mesenchymal|2015|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|74|117289393|Male|Other mesenchymal|2016|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|40|117289393|Male|Other mesenchymal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|150|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|137|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109533809|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|163|109533809|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|110873057|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|172|110873057|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112272700|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|146|112272700|Male|Pilocytic astrocytoma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|574070384|Male|Pilocytic astrocytoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|741|574070384|Male|Pilocytic astrocytoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113556645|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|143|113556645|Male|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114846861|Male|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|149|114846861|Male|Pilocytic astrocytoma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116104785|Male|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|146|116104785|Male|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117289393|Male|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.2|0.1|Malignant|157|117289393|Male|Pilocytic astrocytoma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109533809|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109533809|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|110873057|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|110873057|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|112272700|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|112272700|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|99|574070384|Male|Pineal parenchymal|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|133|574070384|Male|Pineal parenchymal|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113556645|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|36|113556645|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|22|114846861|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|114846861|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116104785|Male|Pineal parenchymal|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|28|116104785|Male|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|117289393|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|117289393|Male|Pineal parenchymal|2016|0.0|0.0|0.0
20+|3.3|3.6|3.4|Benign/Borderline|3414|101938779|Male|Pituitary|2004|3.2|3.5|3.3
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.6|3.9|3.7|Benign/Borderline|3760|103190694|Male|Pituitary|2005|3.5|3.8|3.6
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.8|4.1|3.9|Benign/Borderline|4036|104488268|Male|Pituitary|2006|3.7|4.0|3.9
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|4425|105697783|Male|Pituitary|2007|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.4|4.7|4.5|Benign/Borderline|4814|106947980|Male|Pituitary|2008|4.4|4.6|4.5
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.6|4.9|4.7|Benign/Borderline|5142|108197539|Male|Pituitary|2009|4.6|4.9|4.8
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.7|5.0|4.8|Benign/Borderline|5331|109533809|Male|Pituitary|2010|4.7|5.0|4.9
20+|~|~|~|Malignant|~|109533809|Male|Pituitary|2010|~|~|~
20+|4.7|5.0|4.9|Benign/Borderline|5428|110873057|Male|Pituitary|2011|4.8|5.0|4.9
20+|0.0|0.0|0.0|Malignant|21|110873057|Male|Pituitary|2011|0.0|0.0|0.0
20+|5.0|5.3|5.2|Benign/Borderline|5875|112272700|Male|Pituitary|2012|5.1|5.4|5.2
20+|0.0|0.0|0.0|Malignant|18|112272700|Male|Pituitary|2012|0.0|0.0|0.0
20+|5.0|5.1|5.1|Benign/Borderline|29810|574070384|Male|Pituitary|2012-2016|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|90|574070384|Male|Pituitary|2012-2016|0.0|0.0|0.0
20+|5.0|5.3|5.1|Benign/Borderline|5913|113556645|Male|Pituitary|2013|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|25|113556645|Male|Pituitary|2013|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|5976|114846861|Male|Pituitary|2014|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|22|114846861|Male|Pituitary|2014|0.0|0.0|0.0
20+|5.0|5.3|5.1|Benign/Borderline|6119|116104785|Male|Pituitary|2015|5.1|5.4|5.3
20+|0.0|0.0|0.0|Malignant|16|116104785|Male|Pituitary|2015|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|5927|117289393|Male|Pituitary|2016|4.9|5.2|5.1
20+|~|~|~|Malignant|~|117289393|Male|Pituitary|2016|~|~|~
20+|12.3|12.8|12.6|Benign/Borderline|12243|101938779|Male|Total|2004|11.8|12.2|12.0
20+|10.7|11.1|10.9|Malignant|10645|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.8|14.2|14.0|Benign/Borderline|13849|103190694|Male|Total|2005|13.2|13.6|13.4
20+|10.7|11.1|10.9|Malignant|10805|103190694|Male|Total|2005|10.3|10.7|10.5
20+|14.2|14.6|14.4|Benign/Borderline|14508|104488268|Male|Total|2006|13.7|14.1|13.9
20+|10.5|10.9|10.7|Malignant|10827|104488268|Male|Total|2006|10.2|10.6|10.4
20+|14.5|15.0|14.8|Benign/Borderline|15159|105697783|Male|Total|2007|14.1|14.6|14.3
20+|10.5|10.9|10.7|Malignant|11063|105697783|Male|Total|2007|10.3|10.7|10.5
20+|15.3|15.8|15.6|Benign/Borderline|16277|106947980|Male|Total|2008|15.0|15.5|15.2
20+|10.6|11.0|10.8|Malignant|11353|106947980|Male|Total|2008|10.4|10.8|10.6
20+|16.2|16.7|16.4|Benign/Borderline|17437|108197539|Male|Total|2009|15.9|16.4|16.1
20+|10.5|10.9|10.7|Malignant|11426|108197539|Male|Total|2009|10.4|10.8|10.6
20+|16.2|16.7|16.4|Benign/Borderline|17784|109533809|Male|Total|2010|16.0|16.5|16.2
20+|10.2|10.6|10.4|Malignant|11391|109533809|Male|Total|2010|10.2|10.6|10.4
20+|16.1|16.6|16.4|Benign/Borderline|18084|110873057|Male|Total|2011|16.1|16.6|16.3
20+|10.2|10.6|10.4|Malignant|11628|110873057|Male|Total|2011|10.3|10.7|10.5
20+|16.6|17.1|16.9|Benign/Borderline|18986|112272700|Male|Total|2012|16.7|17.2|16.9
20+|10.0|10.4|10.2|Malignant|11659|112272700|Male|Total|2012|10.2|10.6|10.4
20+|16.7|16.9|16.8|Benign/Borderline|98167|574070384|Male|Total|2012-2016|17.0|17.2|17.1
20+|10.0|10.1|10.0|Malignant|59617|574070384|Male|Total|2012-2016|10.3|10.5|10.4
20+|16.8|17.3|17.0|Benign/Borderline|19510|113556645|Male|Total|2013|16.9|17.4|17.2
20+|10.0|10.3|10.2|Malignant|11827|113556645|Male|Total|2013|10.2|10.6|10.4
20+|16.8|17.3|17.0|Benign/Borderline|19856|114846861|Male|Total|2014|17.0|17.5|17.3
20+|10.1|10.4|10.3|Malignant|12147|114846861|Male|Total|2014|10.4|10.8|10.6
20+|16.8|17.3|17.1|Benign/Borderline|20290|116104785|Male|Total|2015|17.2|17.7|17.5
20+|9.7|10.1|9.9|Malignant|11965|116104785|Male|Total|2015|10.1|10.5|10.3
20+|16.0|16.4|16.2|Benign/Borderline|19525|117289393|Male|Total|2016|16.4|16.9|16.6
20+|9.5|9.9|9.7|Malignant|12019|117289393|Male|Total|2016|10.1|10.4|10.2
20+|2.2|2.4|2.3|Benign/Borderline|2320|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2670|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2642|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2725|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2691|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2871|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2875|109533809|Male|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|23|109533809|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2975|110873057|Male|Tumors of Cranial and Spinal Nerves|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|16|110873057|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3151|112272700|Male|Tumors of Cranial and Spinal Nerves|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|24|112272700|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.7|2.7|Benign/Borderline|16228|574070384|Male|Tumors of Cranial and Spinal Nerves|2012-2016|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|105|574070384|Male|Tumors of Cranial and Spinal Nerves|2012-2016|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3194|113556645|Male|Tumors of Cranial and Spinal Nerves|2013|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|113556645|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.8|3.0|2.9|Benign/Borderline|3431|114846861|Male|Tumors of Cranial and Spinal Nerves|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|22|114846861|Male|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|3355|116104785|Male|Tumors of Cranial and Spinal Nerves|2015|2.8|3.0|2.9
20+|~|~|~|Malignant|~|116104785|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
20+|2.4|2.6|2.5|Benign/Borderline|3097|117289393|Male|Tumors of Cranial and Spinal Nerves|2016|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|23|117289393|Male|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|448|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8965|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|522|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9099|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|557|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9191|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|516|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.8|9.2|9.0|Malignant|9388|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|584|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9641|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.8|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|586|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9722|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.8|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|645|109533809|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.7|9.0|8.8|Malignant|9746|109533809|Male|Tumors of Neuroepthelial Tissue|2010|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|600|110873057|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.6|9.0|8.8|Malignant|9889|110873057|Male|Tumors of Neuroepthelial Tissue|2011|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|621|112272700|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.6
20+|8.5|8.9|8.7|Malignant|9978|112272700|Male|Tumors of Neuroepthelial Tissue|2012|8.7|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|3250|574070384|Male|Tumors of Neuroepthelial Tissue|2012-2016|0.5|0.6|0.6
20+|8.5|8.6|8.5|Malignant|50987|574070384|Male|Tumors of Neuroepthelial Tissue|2012-2016|8.8|9.0|8.9
20+|0.5|0.6|0.5|Benign/Borderline|608|113556645|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.6|0.5
20+|8.5|8.9|8.7|Malignant|10160|113556645|Male|Tumors of Neuroepthelial Tissue|2013|8.8|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|671|114846861|Male|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.6
20+|8.5|8.8|8.7|Malignant|10303|114846861|Male|Tumors of Neuroepthelial Tissue|2014|8.8|9.1|9.0
20+|0.5|0.6|0.6|Benign/Borderline|678|116104785|Male|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.6
20+|8.2|8.6|8.4|Malignant|10219|116104785|Male|Tumors of Neuroepthelial Tissue|2015|8.6|9.0|8.8
20+|0.5|0.6|0.6|Benign/Borderline|672|117289393|Male|Tumors of Neuroepthelial Tissue|2016|0.5|0.6|0.6
20+|8.2|8.5|8.3|Malignant|10327|117289393|Male|Tumors of Neuroepthelial Tissue|2016|8.6|9.0|8.8
20+|3.5|3.7|3.6|Benign/Borderline|3599|101938779|Male|Tumors of Sellar Region|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|4.1|4.0|Benign/Borderline|3991|103190694|Male|Tumors of Sellar Region|2005|3.7|4.0|3.9
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|4.0|4.2|4.1|Benign/Borderline|4227|104488268|Male|Tumors of Sellar Region|2006|3.9|4.2|4.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|4624|105697783|Male|Tumors of Sellar Region|2007|4.2|4.5|4.4
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.6|4.9|4.7|Benign/Borderline|5012|106947980|Male|Tumors of Sellar Region|2008|4.6|4.8|4.7
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5344|108197539|Male|Tumors of Sellar Region|2009|4.8|5.1|4.9
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5533|109533809|Male|Tumors of Sellar Region|2010|4.9|5.2|5.1
20+|~|~|~|Malignant|~|109533809|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.9|5.2|5.0|Benign/Borderline|5622|110873057|Male|Tumors of Sellar Region|2011|4.9|5.2|5.1
20+|0.0|0.0|0.0|Malignant|22|110873057|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.2|5.5|5.4|Benign/Borderline|6091|112272700|Male|Tumors of Sellar Region|2012|5.3|5.6|5.4
20+|0.0|0.0|0.0|Malignant|18|112272700|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.2|5.3|5.3|Benign/Borderline|30899|574070384|Male|Tumors of Sellar Region|2012-2016|5.3|5.4|5.4
20+|0.0|0.0|0.0|Malignant|95|574070384|Male|Tumors of Sellar Region|2012-2016|0.0|0.0|0.0
20+|5.2|5.5|5.3|Benign/Borderline|6136|113556645|Male|Tumors of Sellar Region|2013|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|25|113556645|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.1|5.4|5.3|Benign/Borderline|6178|114846861|Male|Tumors of Sellar Region|2014|5.2|5.5|5.4
20+|0.0|0.0|0.0|Malignant|26|114846861|Male|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|6339|116104785|Male|Tumors of Sellar Region|2015|5.3|5.6|5.5
20+|0.0|0.0|0.0|Malignant|16|116104785|Male|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|4.9|5.2|5.1|Benign/Borderline|6155|117289393|Male|Tumors of Sellar Region|2016|5.1|5.4|5.2
20+|~|~|~|Malignant|~|117289393|Male|Tumors of Sellar Region|2016|~|~|~
20+|5.4|5.7|5.5|Benign/Borderline|5207|101938779|Male|Tumors of the Meninges|2004|5.0|5.2|5.1
20+|0.2|0.2|0.2|Malignant|200|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.9|6.2|6.1|Benign/Borderline|5809|103190694|Male|Tumors of the Meninges|2005|5.5|5.8|5.6
20+|0.2|0.2|0.2|Malignant|194|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.2|6.5|6.4|Benign/Borderline|6205|104488268|Male|Tumors of the Meninges|2006|5.8|6.1|5.9
20+|0.2|0.2|0.2|Malignant|185|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.3|6.6|6.4|Benign/Borderline|6401|105697783|Male|Tumors of the Meninges|2007|5.9|6.2|6.1
20+|0.2|0.2|0.2|Malignant|220|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.7|7.1|6.9|Benign/Borderline|7028|106947980|Male|Tumors of the Meninges|2008|6.4|6.7|6.6
20+|0.2|0.2|0.2|Malignant|197|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.2|7.5|7.3|Benign/Borderline|7569|108197539|Male|Tumors of the Meninges|2009|6.8|7.2|7.0
20+|0.2|0.2|0.2|Malignant|200|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|7.0|7.4|7.2|Benign/Borderline|7601|109533809|Male|Tumors of the Meninges|2010|6.8|7.1|6.9
20+|0.1|0.2|0.1|Malignant|154|109533809|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|7.0|7.3|7.2|Benign/Borderline|7734|110873057|Male|Tumors of the Meninges|2011|6.8|7.1|7.0
20+|0.1|0.2|0.2|Malignant|187|110873057|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|7.0|7.3|7.1|Benign/Borderline|7891|112272700|Male|Tumors of the Meninges|2012|6.9|7.2|7.0
20+|0.1|0.2|0.2|Malignant|183|112272700|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|7.2|7.4|7.3|Benign/Borderline|42181|574070384|Male|Tumors of the Meninges|2012-2016|7.3|7.4|7.3
20+|0.2|0.2|0.2|Malignant|981|574070384|Male|Tumors of the Meninges|2012-2016|0.2|0.2|0.2
20+|7.3|7.6|7.4|Benign/Borderline|8366|113556645|Male|Tumors of the Meninges|2013|7.2|7.5|7.4
20+|0.1|0.2|0.2|Malignant|198|113556645|Male|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|7.2|7.5|7.3|Benign/Borderline|8432|114846861|Male|Tumors of the Meninges|2014|7.2|7.5|7.3
20+|0.2|0.2|0.2|Malignant|216|114846861|Male|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|7.3|7.6|7.5|Benign/Borderline|8843|116104785|Male|Tumors of the Meninges|2015|7.5|7.8|7.6
20+|0.1|0.2|0.2|Malignant|191|116104785|Male|Tumors of the Meninges|2015|0.1|0.2|0.2
20+|7.1|7.4|7.2|Benign/Borderline|8649|117289393|Male|Tumors of the Meninges|2016|7.2|7.5|7.4
20+|0.1|0.2|0.2|Malignant|193|117289393|Male|Tumors of the Meninges|2016|0.1|0.2|0.2
20+|0.6|0.8|0.7|Benign/Borderline|646|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|617|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|825|103190694|Male|Unclassified Tumors|2005|0.7|0.9|0.8
20+|0.6|0.7|0.7|Malignant|611|103190694|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|846|104488268|Male|Unclassified Tumors|2006|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|575|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|857|105697783|Male|Unclassified Tumors|2007|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|575|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|928|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.9
20+|0.6|0.7|0.7|Malignant|628|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1032|108197539|Male|Unclassified Tumors|2009|0.9|1.0|1.0
20+|0.6|0.7|0.7|Malignant|650|108197539|Male|Unclassified Tumors|2009|0.6|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1103|109533809|Male|Unclassified Tumors|2010|0.9|1.1|1.0
20+|0.6|0.7|0.6|Malignant|609|109533809|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1128|110873057|Male|Unclassified Tumors|2011|1.0|1.1|1.0
20+|0.6|0.7|0.6|Malignant|622|110873057|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.2|1.1|Benign/Borderline|1203|112272700|Male|Unclassified Tumors|2012|1.0|1.1|1.1
20+|0.6|0.6|0.6|Malignant|631|112272700|Male|Unclassified Tumors|2012|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|5470|574070384|Male|Unclassified Tumors|2012-2016|0.9|1.0|1.0
20+|0.5|0.6|0.6|Malignant|3143|574070384|Male|Unclassified Tumors|2012-2016|0.5|0.6|0.5
20+|1.0|1.1|1.0|Benign/Borderline|1180|113556645|Male|Unclassified Tumors|2013|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|621|113556645|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.9|1.0|1.0|Benign/Borderline|1117|114846861|Male|Unclassified Tumors|2014|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|677|114846861|Male|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1047|116104785|Male|Unclassified Tumors|2015|0.8|1.0|0.9
20+|0.5|0.6|0.6|Malignant|627|116104785|Male|Unclassified Tumors|2015|0.5|0.6|0.5
20+|0.7|0.9|0.8|Benign/Borderline|923|117289393|Male|Unclassified Tumors|2016|0.7|0.8|0.8
20+|0.5|0.6|0.5|Malignant|587|117289393|Male|Unclassified Tumors|2016|0.5|0.5|0.5
20+|0.1|0.1|0.1|Benign/Borderline|100|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|112|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|138|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|121|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|149|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|159|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|109533809|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109533809|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|186|110873057|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|110873057|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|172|112272700|Male|Unique astrocytoma variants|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|112272700|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|864|574070384|Male|Unique astrocytoma variants|2012-2016|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|160|574070384|Male|Unique astrocytoma variants|2012-2016|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|169|113556645|Male|Unique astrocytoma variants|2013|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|39|113556645|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|175|114846861|Male|Unique astrocytoma variants|2014|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|114846861|Male|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|168|116104785|Male|Unique astrocytoma variants|2015|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|27|116104785|Male|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|180|117289393|Male|Unique astrocytoma variants|2016|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|28|117289393|Male|Unique astrocytoma variants|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|34|226156451|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|226156451|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|228814263|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|228814263|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|231505975|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|231505975|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|201|1182215722|Male and Female|All other|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|238|1182215722|Male and Female|All other|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|233981644|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|233981644|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|27|236506454|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|49|236506454|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|44|238943381|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|238943381|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|241278268|Male and Female|All other|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|241278268|Male and Female|All other|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1236|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1213|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1208|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1202|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1211|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1215|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|1274|226156451|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1276|228814263|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1333|231505975|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Anaplastic astrocytoma|2012-2016|~|~|~
20+|0.6|0.6|0.6|Malignant|7052|1182215722|Male and Female|Anaplastic astrocytoma|2012-2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1424|233981644|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.6|0.6|Malignant|1404|236506454|Male and Female|Anaplastic astrocytoma|2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1471|238943381|Male and Female|Anaplastic astrocytoma|2015|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Anaplastic astrocytoma|2016|~|~|~
20+|0.5|0.6|0.6|Malignant|1420|241278268|Male and Female|Anaplastic astrocytoma|2016|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|394|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|374|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|353|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|341|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|358|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|334|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|324|226156451|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|336|228814263|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|355|231505975|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Anaplastic oligodendroglioma|2012-2016|~|~|~
20+|0.1|0.2|0.2|Malignant|1792|1182215722|Male and Female|Anaplastic oligodendroglioma|2012-2016|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.2|Malignant|372|233981644|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|354|236506454|Male and Female|Anaplastic oligodendroglioma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|352|238943381|Male and Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Anaplastic oligodendroglioma|2016|~|~|~
20+|0.1|0.2|0.2|Malignant|359|241278268|Male and Female|Anaplastic oligodendroglioma|2016|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1205|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1199|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1187|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1160|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1117|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1052|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1087|226156451|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|1040|228814263|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|1044|231505975|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Astrocytoma, NOS|2012-2016|~|~|~
20+|0.4|0.5|0.5|Malignant|5525|1182215722|Male and Female|Astrocytoma, NOS|2012-2016|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.4|Malignant|1008|233981644|Male and Female|Astrocytoma, NOS|2013|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|1074|236506454|Male and Female|Astrocytoma, NOS|2014|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.5|0.5|Malignant|1180|238943381|Male and Female|Astrocytoma, NOS|2015|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Astrocytoma, NOS|2016|~|~|~
20+|0.5|0.5|0.5|Malignant|1219|241278268|Male and Female|Astrocytoma, NOS|2016|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|63|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|89|218481776|Male and Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|76|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|73|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|85|226156451|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226156451|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|82|228814263|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|228814263|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|231505975|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|231505975|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|391|1182215722|Male and Female|Choroid plexus|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|1182215722|Male and Female|Choroid plexus|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|78|233981644|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|233981644|Male and Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|89|236506454|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|236506454|Male and Female|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|83|238943381|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|238943381|Male and Female|Choroid plexus|2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|69|241278268|Male and Female|Choroid plexus|2016|0.0|0.0|0.0
20+|~|~|~|Malignant|~|241278268|Male and Female|Choroid plexus|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|389|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|415|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|393|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|419|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|422|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|432|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|440|226156451|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226156451|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|412|228814263|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228814263|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|439|231505975|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231505975|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2212|1182215722|Male and Female|Craniopharyngioma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1182215722|Male and Female|Craniopharyngioma|2012-2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|466|233981644|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233981644|Male and Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|425|236506454|Male and Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236506454|Male and Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|453|238943381|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238943381|Male and Female|Craniopharyngioma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|429|241278268|Male and Female|Craniopharyngioma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|241278268|Male and Female|Craniopharyngioma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|257|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|293|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|317|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|340|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|369|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|349|226156451|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|250|228814263|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|207|231505975|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Diffuse astrocytoma|2012-2016|~|~|~
20+|0.0|0.1|0.1|Malignant|628|1182215722|Male and Female|Diffuse astrocytoma|2012-2016|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|174|233981644|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|131|236506454|Male and Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|83|238943381|Male and Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Diffuse astrocytoma|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|33|241278268|Male and Female|Diffuse astrocytoma|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|167|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|189|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|216|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|212|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|237|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|197|226156451|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|187|228814263|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|173|231505975|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Embryonal/primitive/medulloblastoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|886|1182215722|Male and Female|Embryonal/primitive/medulloblastoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|184|233981644|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|180|236506454|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|167|238943381|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Embryonal/primitive/medulloblastoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|182|241278268|Male and Female|Embryonal/primitive/medulloblastoma|2016|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|246|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|271|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|307|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|248|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|259|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|277|226156451|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226156451|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|269|228814263|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|228814263|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|291|231505975|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|231505975|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1434|1182215722|Male and Female|Ependymoma variants|2012-2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|1182215722|Male and Female|Ependymoma variants|2012-2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|275|233981644|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|233981644|Male and Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|297|236506454|Male and Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|236506454|Male and Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|291|238943381|Male and Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|238943381|Male and Female|Ependymoma variants|2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|280|241278268|Male and Female|Ependymoma variants|2016|0.1|0.1|0.1
20+|~|~|~|Malignant|~|241278268|Male and Female|Ependymoma variants|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|595|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|602|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|584|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|584|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|634|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|681|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|16|226156451|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|627|226156451|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|228814263|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|593|228814263|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|628|231505975|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|95|1182215722|Male and Female|Ependymoma/anaplastic ependymoma|2012-2016|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|2906|1182215722|Male and Female|Ependymoma/anaplastic ependymoma|2012-2016|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|575|233981644|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|29|236506454|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|562|236506454|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|26|238943381|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|575|238943381|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|18|241278268|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|566|241278268|Male and Female|Ependymoma/anaplastic ependymoma|2016|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|65|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|70|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|82|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|76|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|226156451|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|65|226156451|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|228814263|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|69|228814263|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|231505975|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|231505975|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|286|1182215722|Male and Female|Germ Cell Tumors|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|303|1182215722|Male and Female|Germ Cell Tumors|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|50|233981644|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|233981644|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|236506454|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|68|236506454|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|59|238943381|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238943381|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|241278268|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|73|241278268|Male and Female|Germ Cell Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9562|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.5|Malignant|9704|213511339|Male and Female|Glioblastoma|2005|4.5|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9802|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10186|218481776|Male and Female|Glioblastoma|2007|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10409|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10486|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.5|4.4|Malignant|10731|226156451|Male and Female|Glioblastoma|2010|4.7|4.8|4.7
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10882|228814263|Male and Female|Glioblastoma|2011|4.7|4.8|4.8
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11388|231505975|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Glioblastoma|2012-2016|~|~|~
20+|4.4|4.5|4.4|Malignant|58561|1182215722|Male and Female|Glioblastoma|2012-2016|4.9|5.0|5.0
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Glioblastoma|2013|~|~|~
20+|4.4|4.6|4.5|Malignant|11541|233981644|Male and Female|Glioblastoma|2013|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Glioblastoma|2014|~|~|~
20+|4.3|4.5|4.4|Malignant|11576|236506454|Male and Female|Glioblastoma|2014|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Glioblastoma|2015|~|~|~
20+|4.4|4.5|4.5|Malignant|11972|238943381|Male and Female|Glioblastoma|2015|4.9|5.1|5.0
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Glioblastoma|2016|~|~|~
20+|4.3|4.5|4.4|Malignant|12084|241278268|Male and Female|Glioblastoma|2016|4.9|5.1|5.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|845|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|833|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|216055494|Male and Female|Glioma malignant, NOS|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|842|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|875|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|921|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|969|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|226156451|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|820|226156451|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|26|228814263|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|933|228814263|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|29|231505975|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|921|231505975|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|190|1182215722|Male and Female|Glioma malignant, NOS|2012-2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4747|1182215722|Male and Female|Glioma malignant, NOS|2012-2016|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|30|233981644|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|913|233981644|Male and Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|41|236506454|Male and Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|931|236506454|Male and Female|Glioma malignant, NOS|2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|47|238943381|Male and Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|978|238943381|Male and Female|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|43|241278268|Male and Female|Glioma malignant, NOS|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|1004|241278268|Male and Female|Glioma malignant, NOS|2016|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|455|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|514|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|498|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|473|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|527|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|507|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|528|226156451|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226156451|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|520|228814263|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228814263|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|537|231505975|Male and Female|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|231505975|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2564|1182215722|Male and Female|Hemangioblastoma|2012-2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|1182215722|Male and Female|Hemangioblastoma|2012-2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|504|233981644|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233981644|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|483|236506454|Male and Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236506454|Male and Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|524|238943381|Male and Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238943381|Male and Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|516|241278268|Male and Female|Hemangioblastoma|2016|0.2|0.2|0.2
20+|~|~|~|Malignant|~|241278268|Male and Female|Hemangioblastoma|2016|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|372|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|480|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|545|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|630|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|788|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.4
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|937|223491138|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1095|226156451|Male and Female|Hemangioma|2010|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226156451|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.5|Benign/Borderline|1209|228814263|Male and Female|Hemangioma|2011|0.5|0.6|0.5
20+|~|~|~|Malignant|~|228814263|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1206|231505975|Male and Female|Hemangioma|2012|0.5|0.6|0.5
20+|~|~|~|Malignant|~|231505975|Male and Female|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|5399|1182215722|Male and Female|Hemangioma|2012-2016|0.4|0.5|0.5
20+|0.0|0.0|0.0|Malignant|16|1182215722|Male and Female|Hemangioma|2012-2016|0.0|0.0|0.0
20+|0.5|0.5|0.5|Benign/Borderline|1217|233981644|Male and Female|Hemangioma|2013|0.5|0.6|0.5
20+|~|~|~|Malignant|~|233981644|Male and Female|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1121|236506454|Male and Female|Hemangioma|2014|0.4|0.5|0.5
20+|~|~|~|Malignant|~|236506454|Male and Female|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|972|238943381|Male and Female|Hemangioma|2015|0.4|0.4|0.4
20+|~|~|~|Malignant|~|238943381|Male and Female|Hemangioma|2015|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|883|241278268|Male and Female|Hemangioma|2016|0.3|0.4|0.4
20+|~|~|~|Malignant|~|241278268|Male and Female|Hemangioma|2016|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|50|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|53|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|52|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|52|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|53|226156451|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|42|228814263|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|48|231505975|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Local Extensions from Regional Tumors|2012-2016|~|~|~
20+|0.0|0.0|0.0|Malignant|226|1182215722|Male and Female|Local Extensions from Regional Tumors|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|43|233981644|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|51|236506454|Male and Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|42|238943381|Male and Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Local Extensions from Regional Tumors|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|42|241278268|Male and Female|Local Extensions from Regional Tumors|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1344|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1440|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1436|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1376|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1475|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|1429|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1508|226156451|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1528|228814263|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1457|231505975|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|~|~|~
20+|0.6|0.6|0.6|Malignant|7730|1182215722|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012-2016|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1468|233981644|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.6|Malignant|1631|236506454|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1573|238943381|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|~|~|~
20+|0.6|0.6|0.6|Malignant|1601|241278268|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016|0.6|0.7|0.7
20+|8.8|9.1|8.9|Benign/Borderline|18959|211050944|Male and Female|Meningioma|2004|8.9|9.1|9.0
20+|0.2|0.2|0.2|Malignant|442|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.9|10.1|10.0|Benign/Borderline|21604|213511339|Male and Female|Meningioma|2005|10.0|10.3|10.1
20+|0.2|0.2|0.2|Malignant|434|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.3|10.6|10.5|Benign/Borderline|23040|216055494|Male and Female|Meningioma|2006|10.5|10.8|10.7
20+|0.2|0.2|0.2|Malignant|404|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.6|10.9|10.8|Benign/Borderline|24128|218481776|Male and Female|Meningioma|2007|10.9|11.2|11.0
20+|0.2|0.2|0.2|Malignant|446|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|11.2|11.5|11.4|Benign/Borderline|25922|220975702|Male and Female|Meningioma|2008|11.6|11.9|11.7
20+|0.1|0.2|0.2|Malignant|363|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|11.9|12.2|12.1|Benign/Borderline|28066|223491138|Male and Female|Meningioma|2009|12.4|12.7|12.6
20+|0.1|0.2|0.1|Malignant|351|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.6|11.8|11.7|Benign/Borderline|27666|226156451|Male and Female|Meningioma|2010|12.1|12.4|12.2
20+|0.1|0.2|0.1|Malignant|325|226156451|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.6|11.9|11.7|Benign/Borderline|28199|228814263|Male and Female|Meningioma|2011|12.2|12.5|12.3
20+|0.1|0.2|0.1|Malignant|327|228814263|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|11.7|12.0|11.8|Benign/Borderline|29004|231505975|Male and Female|Meningioma|2012|12.4|12.7|12.5
20+|0.1|0.2|0.1|Malignant|353|231505975|Male and Female|Meningioma|2012|0.1|0.2|0.2
20+|11.9|12.0|11.9|Benign/Borderline|152172|1182215722|Male and Female|Meningioma|2012-2016|12.8|12.9|12.9
20+|0.1|0.1|0.1|Malignant|1750|1182215722|Male and Female|Meningioma|2012-2016|0.1|0.2|0.1
20+|11.8|12.1|11.9|Benign/Borderline|29814|233981644|Male and Female|Meningioma|2013|12.6|12.9|12.7
20+|0.1|0.2|0.2|Malignant|380|233981644|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|11.9|12.1|12.0|Benign/Borderline|30585|236506454|Male and Female|Meningioma|2014|12.8|13.1|12.9
20+|0.1|0.2|0.1|Malignant|381|236506454|Male and Female|Meningioma|2014|0.1|0.2|0.2
20+|12.0|12.3|12.2|Benign/Borderline|31637|238943381|Male and Female|Meningioma|2015|13.1|13.4|13.2
20+|0.1|0.1|0.1|Malignant|333|238943381|Male and Female|Meningioma|2015|0.1|0.2|0.1
20+|11.7|11.9|11.8|Benign/Borderline|31132|241278268|Male and Female|Meningioma|2016|12.8|13.0|12.9
20+|0.1|0.1|0.1|Malignant|303|241278268|Male and Female|Meningioma|2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|492|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|566|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|637|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|586|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|601|220975702|Male and Female|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|677|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|613|226156451|Male and Female|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|634|228814263|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|570|231505975|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Mixed glioma|2012-2016|~|~|~
20+|0.2|0.2|0.2|Malignant|2027|1182215722|Male and Female|Mixed glioma|2012-2016|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Mixed glioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|618|233981644|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Mixed glioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|464|236506454|Male and Female|Mixed glioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|273|238943381|Male and Female|Mixed glioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Mixed glioma|2016|~|~|~
20+|0.0|0.1|0.0|Malignant|102|241278268|Male and Female|Mixed glioma|2016|0.0|0.1|0.0
20+|0.5|0.6|0.6|Benign/Borderline|1193|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1312|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1497|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1322|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1415|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1285|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1425|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1216|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1431|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1369|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1524|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1424|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1473|226156451|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1243|226156451|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|1464|228814263|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1251|228814263|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|1564|231505975|Male and Female|Neoplasm, unspecified|2012|0.6|0.7|0.7
20+|0.5|0.5|0.5|Malignant|1279|231505975|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|7189|1182215722|Male and Female|Neoplasm, unspecified|2012-2016|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|6421|1182215722|Male and Female|Neoplasm, unspecified|2012-2016|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1471|233981644|Male and Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1277|233981644|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1487|236506454|Male and Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1399|236506454|Male and Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|1426|238943381|Male and Female|Neoplasm, unspecified|2015|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1338|238943381|Male and Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.5|0.5|Benign/Borderline|1241|241278268|Male and Female|Neoplasm, unspecified|2016|0.5|0.5|0.5
20+|0.4|0.4|0.4|Malignant|1128|241278268|Male and Female|Neoplasm, unspecified|2016|0.4|0.5|0.5
20+|2.2|2.3|2.3|Benign/Borderline|4867|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5484|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5575|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5657|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5748|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6081|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5885|226156451|Male and Female|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|45|226156451|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6235|228814263|Male and Female|Nerve sheath, benign and malignant|2011|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|228814263|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|6580|231505975|Male and Female|Nerve sheath, benign and malignant|2012|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|50|231505975|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.7|2.7|2.7|Benign/Borderline|33933|1182215722|Male and Female|Nerve sheath, benign and malignant|2012-2016|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|217|1182215722|Male and Female|Nerve sheath, benign and malignant|2012-2016|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|6756|233981644|Male and Female|Nerve sheath, benign and malignant|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|44|233981644|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7083|236506454|Male and Female|Nerve sheath, benign and malignant|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|38|236506454|Male and Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|7008|238943381|Male and Female|Nerve sheath, benign and malignant|2015|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|38|238943381|Male and Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6506|241278268|Male and Female|Nerve sheath, benign and malignant|2016|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|47|241278268|Male and Female|Nerve sheath, benign and malignant|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226156451|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|52|228814263|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|55|231505975|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|30|1182215722|Male and Female|Neuroepithelial|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|273|1182215722|Male and Female|Neuroepithelial|2012-2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|48|233981644|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|58|236506454|Male and Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|66|238943381|Male and Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Neuroepithelial|2016|~|~|~
20+|0.0|0.0|0.0|Malignant|46|241278268|Male and Female|Neuroepithelial|2016|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|315|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|372|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|55|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|387|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|43|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|386|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|45|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|421|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|437|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|481|226156451|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|226156451|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|426|228814263|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|228814263|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|415|231505975|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|42|231505975|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2205|1182215722|Male and Female|Neuronal/glial, neuronal|2012-2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|182|1182215722|Male and Female|Neuronal/glial, neuronal|2012-2016|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|397|233981644|Male and Female|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|233981644|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|452|236506454|Male and Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|236506454|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|482|238943381|Male and Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|238943381|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|459|241278268|Male and Female|Neuronal/glial, neuronal|2016|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|241278268|Male and Female|Neuronal/glial, neuronal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|831|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|800|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|844|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|808|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|765|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|836|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|797|226156451|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|759|228814263|Male and Female|Oligodendroglioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|660|231505975|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Oligodendroglioma|2012-2016|~|~|~
20+|0.3|0.3|0.3|Malignant|3484|1182215722|Male and Female|Oligodendroglioma|2012-2016|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|707|233981644|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Oligodendroglioma|2014|~|~|~
20+|0.3|0.3|0.3|Malignant|714|236506454|Male and Female|Oligodendroglioma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Oligodendroglioma|2015|~|~|~
20+|0.3|0.3|0.3|Malignant|696|238943381|Male and Female|Oligodendroglioma|2015|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Oligodendroglioma|2016|~|~|~
20+|0.3|0.3|0.3|Malignant|707|241278268|Male and Female|Oligodendroglioma|2016|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|150|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|63|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|166|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|76|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|204|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|98|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|198|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|73|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|173|226156451|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|226156451|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|158|228814263|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|75|228814263|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|202|231505975|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|70|231505975|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|901|1182215722|Male and Female|Other mesenchymal|2012-2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|394|1182215722|Male and Female|Other mesenchymal|2012-2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|178|233981644|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|82|233981644|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|177|236506454|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|81|236506454|Male and Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|195|238943381|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|83|238943381|Male and Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|149|241278268|Male and Female|Other mesenchymal|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|241278268|Male and Female|Other mesenchymal|2016|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|275|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|305|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|307|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|305|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|290|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|272|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226156451|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|329|226156451|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228814263|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|333|228814263|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231505975|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|268|231505975|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1182215722|Male and Female|Pilocytic astrocytoma|2012-2016|~|~|~
20+|0.1|0.1|0.1|Malignant|1442|1182215722|Male and Female|Pilocytic astrocytoma|2012-2016|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233981644|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|299|233981644|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236506454|Male and Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|295|236506454|Male and Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238943381|Male and Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|290|238943381|Male and Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|241278268|Male and Female|Pilocytic astrocytoma|2016|~|~|~
20+|0.1|0.1|0.1|Malignant|290|241278268|Male and Female|Pilocytic astrocytoma|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|46|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|47|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|56|226156451|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226156451|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|228814263|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|228814263|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|231505975|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|231505975|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|317|1182215722|Male and Female|Pineal parenchymal|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|267|1182215722|Male and Female|Pineal parenchymal|2012-2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|68|233981644|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|70|233981644|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|236506454|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|236506454|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|238943381|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|238943381|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|241278268|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|241278268|Male and Female|Pineal parenchymal|2016|0.0|0.0|0.0
20+|3.5|3.6|3.6|Benign/Borderline|7509|211050944|Male and Female|Pituitary|2004|3.5|3.6|3.6
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.9|4.1|4.0|Benign/Borderline|8525|213511339|Male and Female|Pituitary|2005|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|37|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|9286|216055494|Male and Female|Pituitary|2006|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|32|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9866|218481776|Male and Female|Pituitary|2007|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|10667|220975702|Male and Female|Pituitary|2008|4.7|4.9|4.8
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|5.1|5.3|5.2|Benign/Borderline|11615|223491138|Male and Female|Pituitary|2009|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|24|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|11765|226156451|Male and Female|Pituitary|2010|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|31|226156451|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|12027|228814263|Male and Female|Pituitary|2011|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|34|228814263|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|12877|231505975|Male and Female|Pituitary|2012|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|33|231505975|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|5.4|5.4|5.4|Benign/Borderline|64691|1182215722|Male and Female|Pituitary|2012-2016|5.4|5.5|5.5
20+|0.0|0.0|0.0|Malignant|156|1182215722|Male and Female|Pituitary|2012-2016|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12814|233981644|Male and Female|Pituitary|2013|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|40|233981644|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12953|236506454|Male and Female|Pituitary|2014|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|35|236506454|Male and Female|Pituitary|2014|0.0|0.0|0.0
20+|5.4|5.6|5.5|Benign/Borderline|13284|238943381|Male and Female|Pituitary|2015|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|31|238943381|Male and Female|Pituitary|2015|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|12763|241278268|Male and Female|Pituitary|2016|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|17|241278268|Male and Female|Pituitary|2016|0.0|0.0|0.0
20+|16.2|16.5|16.4|Benign/Borderline|34771|211050944|Male and Female|Total|2004|16.3|16.6|16.5
20+|9.0|9.3|9.1|Malignant|19385|211050944|Male and Female|Total|2004|9.1|9.3|9.2
20+|18.2|18.6|18.4|Benign/Borderline|39716|213511339|Male and Female|Total|2005|18.4|18.8|18.6
20+|9.0|9.3|9.1|Malignant|19721|213511339|Male and Female|Total|2005|9.1|9.4|9.2
20+|19.0|19.4|19.2|Benign/Borderline|42025|216055494|Male and Female|Total|2006|19.3|19.6|19.5
20+|8.9|9.2|9.0|Malignant|19806|216055494|Male and Female|Total|2006|9.0|9.3|9.2
20+|19.5|19.9|19.7|Benign/Borderline|43841|218481776|Male and Female|Total|2007|19.9|20.3|20.1
20+|8.9|9.1|9.0|Malignant|20128|218481776|Male and Female|Total|2007|9.1|9.3|9.2
20+|20.5|20.9|20.7|Benign/Borderline|46863|220975702|Male and Female|Total|2008|21.0|21.4|21.2
20+|8.9|9.2|9.1|Malignant|20578|220975702|Male and Female|Total|2008|9.2|9.4|9.3
20+|21.8|22.2|22.0|Benign/Borderline|50545|223491138|Male and Female|Total|2009|22.4|22.8|22.6
20+|8.9|9.1|9.0|Malignant|20793|223491138|Male and Female|Total|2009|9.2|9.4|9.3
20+|21.3|21.7|21.5|Benign/Borderline|50286|226156451|Male and Female|Total|2010|22.0|22.4|22.2
20+|8.7|8.9|8.8|Malignant|20691|226156451|Male and Female|Total|2010|9.0|9.3|9.1
20+|21.5|21.9|21.7|Benign/Borderline|51456|228814263|Male and Female|Total|2011|22.3|22.7|22.5
20+|8.5|8.8|8.7|Malignant|20816|228814263|Male and Female|Total|2011|9.0|9.2|9.1
20+|22.0|22.4|22.2|Benign/Borderline|53633|231505975|Male and Female|Total|2012|23.0|23.4|23.2
20+|8.5|8.7|8.6|Malignant|21117|231505975|Male and Female|Total|2012|9.0|9.2|9.1
20+|22.0|22.2|22.1|Benign/Borderline|275450|1182215722|Male and Female|Total|2012-2016|23.2|23.4|23.3
20+|8.4|8.5|8.5|Malignant|107453|1182215722|Male and Female|Total|2012-2016|9.0|9.1|9.1
20+|22.0|22.4|22.2|Benign/Borderline|54416|233981644|Male and Female|Total|2013|23.1|23.5|23.3
20+|8.5|8.7|8.6|Malignant|21446|233981644|Male and Female|Total|2013|9.0|9.3|9.2
20+|22.1|22.5|22.3|Benign/Borderline|55646|236506454|Male and Female|Total|2014|23.3|23.7|23.5
20+|8.4|8.6|8.5|Malignant|21616|236506454|Male and Female|Total|2014|9.0|9.3|9.1
20+|22.2|22.6|22.4|Benign/Borderline|56848|238943381|Male and Female|Total|2015|23.6|24.0|23.8
20+|8.3|8.5|8.4|Malignant|21771|238943381|Male and Female|Total|2015|9.0|9.2|9.1
20+|21.2|21.6|21.4|Benign/Borderline|54907|241278268|Male and Female|Total|2016|22.6|22.9|22.8
20+|8.0|8.3|8.2|Malignant|21503|241278268|Male and Female|Total|2016|8.8|9.0|8.9
20+|2.2|2.3|2.3|Benign/Borderline|4867|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|5487|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5577|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5659|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5752|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6088|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5889|226156451|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|45|226156451|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6240|228814263|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.7|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|228814263|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|6582|231505975|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|50|231505975|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.7|2.7|2.7|Benign/Borderline|33966|1182215722|Male and Female|Tumors of Cranial and Spinal Nerves|2012-2016|2.8|2.9|2.9
20+|0.0|0.0|0.0|Malignant|217|1182215722|Male and Female|Tumors of Cranial and Spinal Nerves|2012-2016|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|6761|233981644|Male and Female|Tumors of Cranial and Spinal Nerves|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|44|233981644|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.8|2.9|2.8|Benign/Borderline|7092|236506454|Male and Female|Tumors of Cranial and Spinal Nerves|2014|2.9|3.1|3.0
20+|0.0|0.0|0.0|Malignant|38|236506454|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|7018|238943381|Male and Female|Tumors of Cranial and Spinal Nerves|2015|2.9|3.0|2.9
20+|0.0|0.0|0.0|Malignant|38|238943381|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|6513|241278268|Male and Female|Tumors of Cranial and Spinal Nerves|2016|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|47|241278268|Male and Female|Tumors of Cranial and Spinal Nerves|2016|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|830|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.7|7.5|Malignant|16022|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|963|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16244|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1039|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16415|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|996|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16774|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1072|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17061|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1096|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17338|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.6|7.9|7.8
20+|0.5|0.6|0.5|Benign/Borderline|1192|226156451|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|7.2|7.5|7.3|Malignant|17332|226156451|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1159|228814263|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.1|7.4|7.3|Malignant|17430|228814263|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1156|231505975|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.1|7.4|7.2|Malignant|17759|231505975|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|6043|1182215722|Male and Female|Tumors of Neuroepthelial Tissue|2012-2016|0.5|0.5|0.5
20+|7.1|7.2|7.1|Malignant|90145|1182215722|Male and Female|Tumors of Neuroepthelial Tissue|2012-2016|7.6|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1133|233981644|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.5|0.5|0.5
20+|7.1|7.4|7.2|Malignant|18042|233981644|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1261|236506454|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|17902|236506454|Male and Female|Tumors of Neuroepthelial Tissue|2014|7.5|7.7|7.6
20+|0.5|0.6|0.5|Benign/Borderline|1274|238943381|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.5
20+|7.0|7.2|7.1|Malignant|18252|238943381|Male and Female|Tumors of Neuroepthelial Tissue|2015|7.5|7.8|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1219|241278268|Male and Female|Tumors of Neuroepthelial Tissue|2016|0.5|0.5|0.5
20+|6.8|7.0|6.9|Malignant|18190|241278268|Male and Female|Tumors of Neuroepthelial Tissue|2016|7.4|7.6|7.5
20+|3.7|3.8|3.7|Benign/Borderline|7898|211050944|Male and Female|Tumors of Sellar Region|2004|3.7|3.8|3.7
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|8940|213511339|Male and Female|Tumors of Sellar Region|2005|4.1|4.3|4.2
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|9679|216055494|Male and Female|Tumors of Sellar Region|2006|4.4|4.6|4.5
20+|0.0|0.0|0.0|Malignant|34|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|10285|218481776|Male and Female|Tumors of Sellar Region|2007|4.6|4.8|4.7
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|11089|220975702|Male and Female|Tumors of Sellar Region|2008|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|16|220975702|Male and Female|Tumors of Sellar Region|2008|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12047|223491138|Male and Female|Tumors of Sellar Region|2009|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|25|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.3|5.4|5.4|Benign/Borderline|12205|226156451|Male and Female|Tumors of Sellar Region|2010|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|31|226156451|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12439|228814263|Male and Female|Tumors of Sellar Region|2011|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|36|228814263|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13316|231505975|Male and Female|Tumors of Sellar Region|2012|5.7|5.9|5.8
20+|0.0|0.0|0.0|Malignant|33|231505975|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.5|5.6|5.6|Benign/Borderline|66903|1182215722|Male and Female|Tumors of Sellar Region|2012-2016|5.6|5.7|5.7
20+|0.0|0.0|0.0|Malignant|164|1182215722|Male and Female|Tumors of Sellar Region|2012-2016|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13280|233981644|Male and Female|Tumors of Sellar Region|2013|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|41|233981644|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13378|236506454|Male and Female|Tumors of Sellar Region|2014|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|40|236506454|Male and Female|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.6|5.8|5.7|Benign/Borderline|13737|238943381|Male and Female|Tumors of Sellar Region|2015|5.7|5.8|5.7
20+|0.0|0.0|0.0|Malignant|32|238943381|Male and Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|13192|241278268|Male and Female|Tumors of Sellar Region|2016|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|18|241278268|Male and Female|Tumors of Sellar Region|2016|0.0|0.0|0.0
20+|9.1|9.3|9.2|Benign/Borderline|19564|211050944|Male and Female|Tumors of the Meninges|2004|9.1|9.4|9.3
20+|0.2|0.3|0.2|Malignant|499|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.2|10.4|10.3|Benign/Borderline|22274|213511339|Male and Female|Tumors of the Meninges|2005|10.3|10.6|10.4
20+|0.2|0.3|0.2|Malignant|500|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.6|10.9|10.8|Benign/Borderline|23693|216055494|Male and Female|Tumors of the Meninges|2006|10.8|11.1|11.0
20+|0.2|0.2|0.2|Malignant|467|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.9|11.2|11.1|Benign/Borderline|24767|218481776|Male and Female|Tumors of the Meninges|2007|11.2|11.5|11.3
20+|0.2|0.3|0.2|Malignant|529|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.5|11.8|11.7|Benign/Borderline|26653|220975702|Male and Female|Tumors of the Meninges|2008|11.9|12.2|12.1
20+|0.2|0.2|0.2|Malignant|466|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|12.3|12.5|12.4|Benign/Borderline|28771|223491138|Male and Female|Tumors of the Meninges|2009|12.7|13.0|12.9
20+|0.2|0.2|0.2|Malignant|427|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|11.9|12.1|12.0|Benign/Borderline|28367|226156451|Male and Female|Tumors of the Meninges|2010|12.4|12.7|12.5
20+|0.1|0.2|0.2|Malignant|394|226156451|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|11.9|12.2|12.0|Benign/Borderline|28877|228814263|Male and Female|Tumors of the Meninges|2011|12.5|12.8|12.6
20+|0.2|0.2|0.2|Malignant|403|228814263|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|12.0|12.3|12.1|Benign/Borderline|29743|231505975|Male and Female|Tumors of the Meninges|2012|12.7|13.0|12.8
20+|0.2|0.2|0.2|Malignant|423|231505975|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|12.2|12.3|12.2|Benign/Borderline|155637|1182215722|Male and Female|Tumors of the Meninges|2012-2016|13.1|13.2|13.2
20+|0.2|0.2|0.2|Malignant|2168|1182215722|Male and Female|Tumors of the Meninges|2012-2016|0.2|0.2|0.2
20+|12.1|12.4|12.2|Benign/Borderline|30496|233981644|Male and Female|Tumors of the Meninges|2013|12.9|13.2|13.0
20+|0.2|0.2|0.2|Malignant|466|233981644|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|12.1|12.4|12.3|Benign/Borderline|31245|236506454|Male and Female|Tumors of the Meninges|2014|13.1|13.4|13.2
20+|0.2|0.2|0.2|Malignant|469|236506454|Male and Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|12.3|12.6|12.5|Benign/Borderline|32356|238943381|Male and Female|Tumors of the Meninges|2015|13.4|13.7|13.5
20+|0.1|0.2|0.2|Malignant|421|238943381|Male and Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|11.9|12.2|12.1|Benign/Borderline|31797|241278268|Male and Female|Tumors of the Meninges|2016|13.0|13.3|13.2
20+|0.1|0.2|0.1|Malignant|389|241278268|Male and Female|Tumors of the Meninges|2016|0.1|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1571|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1325|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1982|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1335|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1970|216055494|Male and Female|Unclassified Tumors|2006|0.9|1.0|0.9
20+|0.6|0.6|0.6|Malignant|1301|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2061|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1227|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|2229|220975702|Male and Female|Unclassified Tumors|2008|1.0|1.1|1.0
20+|0.6|0.6|0.6|Malignant|1393|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2464|223491138|Male and Female|Unclassified Tumors|2009|1.1|1.1|1.1
20+|0.6|0.7|0.6|Malignant|1442|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2573|226156451|Male and Female|Unclassified Tumors|2010|1.1|1.2|1.1
20+|0.5|0.6|0.5|Malignant|1263|226156451|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2679|228814263|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1272|228814263|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|2771|231505975|Male and Female|Unclassified Tumors|2012|1.2|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1295|231505975|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|12606|1182215722|Male and Female|Unclassified Tumors|2012-2016|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|6500|1182215722|Male and Female|Unclassified Tumors|2012-2016|0.5|0.6|0.5
20+|1.1|1.2|1.1|Benign/Borderline|2695|233981644|Male and Female|Unclassified Tumors|2013|1.1|1.2|1.2
20+|0.5|0.5|0.5|Malignant|1291|233981644|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2611|236506454|Male and Female|Unclassified Tumors|2014|1.1|1.1|1.1
20+|0.5|0.6|0.5|Malignant|1417|236506454|Male and Female|Unclassified Tumors|2014|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2402|238943381|Male and Female|Unclassified Tumors|2015|1.0|1.0|1.0
20+|0.5|0.5|0.5|Malignant|1354|238943381|Male and Female|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.8|0.9|0.8|Benign/Borderline|2127|241278268|Male and Female|Unclassified Tumors|2016|0.8|0.9|0.9
20+|0.4|0.5|0.4|Malignant|1143|241278268|Male and Female|Unclassified Tumors|2016|0.4|0.5|0.5
20+|0.1|0.1|0.1|Benign/Borderline|154|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|187|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|183|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|206|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|234|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|65|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|254|226156451|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|226156451|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|266|228814263|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|60|228814263|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|270|231505975|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|231505975|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1353|1182215722|Male and Female|Unique astrocytoma variants|2012-2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|317|1182215722|Male and Female|Unique astrocytoma variants|2012-2016|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|264|233981644|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|233981644|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|272|236506454|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|78|236506454|Male and Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|269|238943381|Male and Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|238943381|Male and Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|278|241278268|Male and Female|Unique astrocytoma variants|2016|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|64|241278268|Male and Female|Unique astrocytoma variants|2016|0.0|0.0|0.0